Gene Symbol | Gene ID | Gene Info |
---|---|---|
SP4
|
ENSG00000105866.9 | Sp4 transcription factor |
PML
|
ENSG00000140464.15 | PML nuclear body scaffold |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr15_74324863_74325014 | PML | 7717 | 0.157797 | 0.78 | 1.3e-02 | Click! |
chr15_74317615_74317766 | PML | 469 | 0.778378 | -0.76 | 1.7e-02 | Click! |
chr15_74287580_74287731 | PML | 511 | 0.536340 | 0.68 | 4.2e-02 | Click! |
chr15_74325155_74325331 | PML | 8022 | 0.156760 | 0.61 | 8.2e-02 | Click! |
chr15_74299694_74300033 | PML | 12719 | 0.148300 | 0.53 | 1.4e-01 | Click! |
chr7_21468175_21468420 | SP4 | 636 | 0.720536 | 0.73 | 2.6e-02 | Click! |
chr7_21465952_21466638 | SP4 | 1357 | 0.425807 | 0.65 | 5.9e-02 | Click! |
chr7_21480521_21480672 | SP4 | 12935 | 0.182541 | -0.59 | 9.1e-02 | Click! |
chr7_21468477_21468637 | SP4 | 896 | 0.591037 | 0.54 | 1.3e-01 | Click! |
chr7_21470289_21470479 | SP4 | 2723 | 0.266498 | 0.54 | 1.4e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr17_72984009_72984428 | 1.25 |
CDR2L |
cerebellar degeneration-related protein 2-like |
491 |
0.63 |
chr17_63556647_63556944 | 1.19 |
AXIN2 |
axin 2 |
120 |
0.98 |
chr17_8025338_8025489 | 1.16 |
HES7 |
hes family bHLH transcription factor 7 |
1989 |
0.15 |
chr7_24796635_24796939 | 1.01 |
DFNA5 |
deafness, autosomal dominant 5 |
307 |
0.94 |
chr7_19156075_19156556 | 0.94 |
TWIST1 |
twist family bHLH transcription factor 1 |
980 |
0.47 |
chr11_4208528_4208828 | 0.92 |
RRM1-AS1 |
RRM1 antisense RNA 1 |
49191 |
0.14 |
chr17_1082802_1083000 | 0.84 |
ABR |
active BCR-related |
177 |
0.94 |
chr2_227664099_227664289 | 0.79 |
IRS1 |
insulin receptor substrate 1 |
281 |
0.92 |
chr10_15130737_15130888 | 0.78 |
ACBD7 |
acyl-CoA binding domain containing 7 |
37 |
0.97 |
chr10_31609488_31609880 | 0.76 |
ENSG00000237036 |
. |
308 |
0.56 |
chr3_98620084_98620269 | 0.75 |
DCBLD2 |
discoidin, CUB and LCCL domain containing 2 |
6 |
0.96 |
chr2_71693709_71693860 | 0.75 |
DYSF |
dysferlin |
48 |
0.98 |
chr13_100621996_100622147 | 0.74 |
ZIC5 |
Zic family member 5 |
2092 |
0.31 |
chr6_127836755_127837132 | 0.73 |
SOGA3 |
SOGA family member 3 |
816 |
0.71 |
chr6_17281167_17281463 | 0.71 |
RBM24 |
RNA binding motif protein 24 |
262 |
0.95 |
chr9_139694082_139694314 | 0.70 |
CCDC183 |
coiled-coil domain containing 183 |
3383 |
0.09 |
chr11_86665978_86666264 | 0.70 |
FZD4 |
frizzled family receptor 4 |
312 |
0.92 |
chr3_184286763_184286975 | 0.69 |
EPHB3 |
EPH receptor B3 |
7297 |
0.2 |
chr2_111880585_111880736 | 0.69 |
BCL2L11 |
BCL2-like 11 (apoptosis facilitator) |
413 |
0.88 |
chr1_167424277_167424611 | 0.69 |
RP11-104L21.2 |
|
3454 |
0.27 |
chr8_81490427_81490652 | 0.69 |
ENSG00000223327 |
. |
7469 |
0.23 |
chr18_59561361_59561512 | 0.69 |
RNF152 |
ring finger protein 152 |
28 |
0.99 |
chr20_57225612_57225784 | 0.68 |
STX16 |
syntaxin 16 |
630 |
0.69 |
chr17_8534051_8534202 | 0.68 |
MYH10 |
myosin, heavy chain 10, non-muscle |
47 |
0.98 |
chr19_1237451_1237667 | 0.68 |
C19orf26 |
chromosome 19 open reading frame 26 |
431 |
0.67 |
chr12_64237996_64238246 | 0.68 |
SRGAP1 |
SLIT-ROBO Rho GTPase activating protein 1 |
48 |
0.97 |
chr17_79422189_79422386 | 0.68 |
ENSG00000266189 |
. |
4073 |
0.12 |
chr22_19419614_19419913 | 0.68 |
MRPL40 |
mitochondrial ribosomal protein L40 |
338 |
0.57 |
chr11_63381674_63381962 | 0.68 |
PLA2G16 |
phospholipase A2, group XVI |
23 |
0.96 |
chr7_138720207_138720441 | 0.68 |
ZC3HAV1L |
zinc finger CCCH-type, antiviral 1-like |
451 |
0.85 |
chr2_71192233_71192438 | 0.68 |
ENSG00000241159 |
. |
366 |
0.69 |
chr2_175201668_175201819 | 0.68 |
AC018470.1 |
Uncharacterized protein FLJ46347 |
408 |
0.8 |
chr8_38325731_38325987 | 0.67 |
FGFR1 |
fibroblast growth factor receptor 1 |
275 |
0.9 |
chr2_54684015_54684166 | 0.67 |
SPTBN1 |
spectrin, beta, non-erythrocytic 1 |
308 |
0.93 |
chr19_50432510_50432661 | 0.67 |
NUP62 |
nucleoporin 62kDa |
101 |
0.37 |
chr19_13976503_13976787 | 0.67 |
ENSG00000207613 |
. |
8868 |
0.08 |
chr13_113622812_113623113 | 0.66 |
MCF2L |
MCF.2 cell line derived transforming sequence-like |
148 |
0.53 |
chr7_100137037_100137226 | 0.66 |
AGFG2 |
ArfGAP with FG repeats 2 |
249 |
0.83 |
chr15_63334942_63335093 | 0.66 |
TPM1 |
tropomyosin 1 (alpha) |
60 |
0.97 |
chr2_136633685_136633836 | 0.65 |
MCM6 |
minichromosome maintenance complex component 6 |
236 |
0.93 |
chr9_4297910_4298061 | 0.65 |
GLIS3 |
GLIS family zinc finger 3 |
511 |
0.74 |
chr12_26985476_26985627 | 0.65 |
ITPR2 |
inositol 1,4,5-trisphosphate receptor, type 2 |
163 |
0.97 |
chr20_25370918_25371069 | 0.64 |
ABHD12 |
abhydrolase domain containing 12 |
223 |
0.94 |
chr17_76310134_76310416 | 0.64 |
SOCS3 |
suppressor of cytokine signaling 3 |
45880 |
0.1 |
chr20_2672991_2673142 | 0.63 |
EBF4 |
early B-cell factor 4 |
458 |
0.68 |
chr5_114880195_114880346 | 0.63 |
FEM1C |
fem-1 homolog c (C. elegans) |
321 |
0.91 |
chr1_78354156_78354308 | 0.62 |
NEXN |
nexilin (F actin binding protein) |
32 |
0.95 |
chr1_71513323_71513584 | 0.62 |
PTGER3 |
prostaglandin E receptor 3 (subtype EP3) |
18 |
0.95 |
chr11_34074190_34074341 | 0.62 |
CAPRIN1 |
cell cycle associated protein 1 |
263 |
0.94 |
chr19_52005125_52005479 | 0.61 |
SIGLEC12 |
sialic acid binding Ig-like lectin 12 (gene/pseudogene) |
259 |
0.85 |
chr17_79849821_79850029 | 0.61 |
ANAPC11 |
anaphase promoting complex subunit 11 |
14 |
0.85 |
chr17_48277708_48277975 | 0.61 |
COL1A1 |
collagen, type I, alpha 1 |
289 |
0.84 |
chr3_142682564_142682790 | 0.61 |
RP11-372E1.6 |
|
223 |
0.66 |
chr1_220921776_220921927 | 0.61 |
MARC2 |
mitochondrial amidoxime reducing component 2 |
175 |
0.95 |
chr2_227663405_227663664 | 0.61 |
IRS1 |
insulin receptor substrate 1 |
941 |
0.59 |
chr20_62338553_62338786 | 0.60 |
ZGPAT |
zinc finger, CCCH-type with G patch domain |
148 |
0.7 |
chr16_30797936_30798087 | 0.60 |
ZNF629 |
zinc finger protein 629 |
512 |
0.62 |
chr4_15004584_15004759 | 0.60 |
CPEB2 |
cytoplasmic polyadenylation element binding protein 2 |
373 |
0.92 |
chr17_79989148_79989299 | 0.60 |
RAC3 |
ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) |
277 |
0.76 |
chr2_97535201_97535472 | 0.59 |
SEMA4C |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4C |
372 |
0.81 |
chr14_55033500_55033670 | 0.59 |
SAMD4A |
sterile alpha motif domain containing 4A |
230 |
0.95 |
chr17_43096466_43096635 | 0.59 |
DCAKD |
dephospho-CoA kinase domain containing |
15959 |
0.12 |
chr19_3366959_3367260 | 0.59 |
NFIC |
nuclear factor I/C (CCAAT-binding transcription factor) |
525 |
0.78 |
chr11_101981093_101981244 | 0.59 |
YAP1 |
Yes-associated protein 1 |
24 |
0.97 |
chr6_143267599_143267750 | 0.59 |
HIVEP2 |
human immunodeficiency virus type I enhancer binding protein 2 |
1336 |
0.54 |
chr4_120548640_120548978 | 0.59 |
PDE5A |
phosphodiesterase 5A, cGMP-specific |
21 |
0.99 |
chr22_29702784_29703085 | 0.59 |
GAS2L1 |
growth arrest-specific 2 like 1 |
79 |
0.95 |
chr1_155163105_155163422 | 0.59 |
MUC1 |
mucin 1, cell surface associated |
557 |
0.42 |
chrX_71130790_71130953 | 0.59 |
NHSL2 |
NHS-like 2 |
67 |
0.98 |
chr19_13266437_13266669 | 0.58 |
CTC-250I14.6 |
|
1546 |
0.23 |
chr22_30642550_30642701 | 0.58 |
LIF |
leukemia inhibitory factor |
103 |
0.82 |
chr15_73344221_73344400 | 0.58 |
NEO1 |
neogenin 1 |
259 |
0.96 |
chr1_86042878_86043159 | 0.58 |
DDAH1 |
dimethylarginine dimethylaminohydrolase 1 |
915 |
0.56 |
chr15_45459341_45459602 | 0.58 |
RP11-519G16.2 |
|
3071 |
0.13 |
chr16_23569360_23569511 | 0.58 |
EARS2 |
glutamyl-tRNA synthetase 2, mitochondrial |
383 |
0.45 |
chr9_101983780_101983931 | 0.58 |
ALG2 |
ALG2, alpha-1,3/1,6-mannosyltransferase |
383 |
0.56 |
chr6_97285293_97285444 | 0.57 |
GPR63 |
G protein-coupled receptor 63 |
15 |
0.98 |
chr16_88713940_88714131 | 0.57 |
CYBA |
cytochrome b-245, alpha polypeptide |
802 |
0.42 |
chr22_50913528_50913679 | 0.57 |
SBF1 |
SET binding factor 1 |
149 |
0.9 |
chr2_232526773_232526924 | 0.57 |
ENSG00000239202 |
. |
15864 |
0.16 |
chr1_17764676_17764827 | 0.56 |
RCC2 |
regulator of chromosome condensation 2 |
306 |
0.88 |
chr16_2390606_2390757 | 0.56 |
ABCA3 |
ATP-binding cassette, sub-family A (ABC1), member 3 |
55 |
0.95 |
chr16_57318446_57318597 | 0.56 |
PLLP |
plasmolipin |
63 |
0.96 |
chr3_38070737_38070996 | 0.56 |
PLCD1 |
phospholipase C, delta 1 |
387 |
0.8 |
chr4_77871771_77872019 | 0.56 |
SEPT11 |
septin 11 |
880 |
0.67 |
chr12_49212131_49212282 | 0.56 |
CACNB3 |
calcium channel, voltage-dependent, beta 3 subunit |
61 |
0.95 |
chr17_78010460_78010611 | 0.56 |
CCDC40 |
coiled-coil domain containing 40 |
75 |
0.93 |
chr1_161697050_161697268 | 0.56 |
FCRLB |
Fc receptor-like B |
4702 |
0.12 |
chr17_1478387_1478674 | 0.56 |
PITPNA |
phosphatidylinositol transfer protein, alpha |
12420 |
0.11 |
chr15_41877601_41877752 | 0.56 |
TYRO3 |
TYRO3 protein tyrosine kinase |
14801 |
0.15 |
chr3_46940291_46940541 | 0.56 |
PTH1R |
parathyroid hormone 1 receptor |
3673 |
0.18 |
chr12_57483024_57483175 | 0.56 |
NAB2 |
NGFI-A binding protein 2 (EGR1 binding protein 2) |
209 |
0.88 |
chr10_97415945_97416132 | 0.56 |
ALDH18A1 |
aldehyde dehydrogenase 18 family, member A1 |
425 |
0.86 |
chr13_27132297_27132561 | 0.55 |
WASF3 |
WAS protein family, member 3 |
542 |
0.86 |
chr1_95392582_95392733 | 0.55 |
CNN3 |
calponin 3, acidic |
19 |
0.89 |
chr12_7023886_7024037 | 0.55 |
ENO2 |
enolase 2 (gamma, neuronal) |
187 |
0.83 |
chr10_88471165_88471428 | 0.55 |
ENSG00000252189 |
. |
34410 |
0.12 |
chr5_132165870_132166087 | 0.55 |
SHROOM1 |
shroom family member 1 |
373 |
0.78 |
chr7_2393665_2393816 | 0.55 |
EIF3B |
eukaryotic translation initiation factor 3, subunit B |
19 |
0.73 |
chr5_37249611_37249762 | 0.55 |
C5orf42 |
chromosome 5 open reading frame 42 |
156 |
0.96 |
chr6_132272068_132272363 | 0.55 |
RP11-69I8.3 |
|
129 |
0.72 |
chr11_125496038_125496275 | 0.55 |
CHEK1 |
checkpoint kinase 1 |
32 |
0.97 |
chr9_88357147_88357298 | 0.55 |
AGTPBP1 |
ATP/GTP binding protein 1 |
278 |
0.96 |
chr17_19770414_19770638 | 0.55 |
ULK2 |
unc-51 like autophagy activating kinase 2 |
704 |
0.71 |
chr6_36853795_36853946 | 0.55 |
C6orf89 |
chromosome 6 open reading frame 89 |
230 |
0.92 |
chr1_182360343_182360566 | 0.55 |
GLUL |
glutamate-ammonia ligase |
85 |
0.97 |
chr8_131370141_131370292 | 0.55 |
ASAP1 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 |
17033 |
0.29 |
chr14_105953591_105953742 | 0.55 |
CRIP1 |
cysteine-rich protein 1 (intestinal) |
412 |
0.72 |
chr19_52193071_52193310 | 0.54 |
ENSG00000207550 |
. |
2675 |
0.13 |
chr17_31254814_31254990 | 0.54 |
TMEM98 |
transmembrane protein 98 |
26 |
0.98 |
chr9_38068361_38068574 | 0.54 |
SHB |
Src homology 2 domain containing adaptor protein B |
741 |
0.75 |
chr3_114865437_114865588 | 0.54 |
ZBTB20 |
zinc finger and BTB domain containing 20 |
606 |
0.86 |
chr15_39873345_39873496 | 0.54 |
THBS1 |
thrombospondin 1 |
126 |
0.96 |
chr14_23306505_23306782 | 0.54 |
MMP14 |
matrix metallopeptidase 14 (membrane-inserted) |
122 |
0.91 |
chr11_45944455_45944606 | 0.54 |
GYLTL1B |
glycosyltransferase-like 1B |
201 |
0.9 |
chr7_151107012_151107163 | 0.53 |
WDR86 |
WD repeat domain 86 |
19 |
0.93 |
chr4_85886857_85887120 | 0.53 |
WDFY3 |
WD repeat and FYVE domain containing 3 |
515 |
0.87 |
chr2_65658777_65658974 | 0.53 |
SPRED2 |
sprouty-related, EVH1 domain containing 2 |
436 |
0.88 |
chr17_49021895_49022046 | 0.53 |
SPAG9 |
sperm associated antigen 9 |
49328 |
0.11 |
chr20_55973494_55973645 | 0.53 |
RP4-800J21.3 |
|
5451 |
0.16 |
chr6_43477877_43478028 | 0.53 |
LRRC73 |
leucine rich repeat containing 73 |
472 |
0.41 |
chr22_37956709_37956998 | 0.53 |
CDC42EP1 |
CDC42 effector protein (Rho GTPase binding) 1 |
366 |
0.79 |
chr11_10952893_10953186 | 0.52 |
ZBED5-AS1 |
ZBED5 antisense RNA 1 |
66231 |
0.1 |
chr20_4152983_4153134 | 0.52 |
SMOX |
spermine oxidase |
701 |
0.72 |
chr12_124458252_124458403 | 0.52 |
ZNF664 |
zinc finger protein 664 |
485 |
0.36 |
chr2_225906903_225907054 | 0.52 |
DOCK10 |
dedicator of cytokinesis 10 |
181 |
0.97 |
chr9_131940185_131940426 | 0.52 |
IER5L |
immediate early response 5-like |
235 |
0.84 |
chr8_97506971_97507442 | 0.52 |
SDC2 |
syndecan 2 |
970 |
0.67 |
chr4_8161119_8161320 | 0.52 |
ABLIM2 |
actin binding LIM protein family, member 2 |
660 |
0.74 |
chr17_79370300_79370599 | 0.52 |
RP11-1055B8.6 |
Uncharacterized protein |
1174 |
0.33 |
chr5_129240696_129240863 | 0.52 |
CTC-575N7.1 |
|
575 |
0.48 |
chr1_26232775_26232926 | 0.52 |
ENSG00000264021 |
. |
95 |
0.5 |
chr4_55099953_55100185 | 0.52 |
PDGFRA |
platelet-derived growth factor receptor, alpha polypeptide |
3580 |
0.33 |
chr15_100881160_100881350 | 0.52 |
ADAMTS17 |
ADAM metallopeptidase with thrombospondin type 1 motif, 17 |
86 |
0.98 |
chr4_7043959_7044306 | 0.52 |
TADA2B |
transcriptional adaptor 2B |
506 |
0.46 |
chr4_156681067_156681218 | 0.52 |
GUCY1B3 |
guanylate cyclase 1, soluble, beta 3 |
531 |
0.82 |
chr10_118501252_118501433 | 0.52 |
HSPA12A |
heat shock 70kDa protein 12A |
743 |
0.71 |
chr21_35986728_35986879 | 0.52 |
RCAN1 |
regulator of calcineurin 1 |
58 |
0.98 |
chr10_33624260_33624479 | 0.52 |
NRP1 |
neuropilin 1 |
363 |
0.91 |
chr5_141736312_141736463 | 0.52 |
AC005592.2 |
|
3279 |
0.31 |
chr14_61189252_61189438 | 0.51 |
SIX4 |
SIX homeobox 4 |
1507 |
0.43 |
chr7_100806827_100806983 | 0.51 |
VGF |
VGF nerve growth factor inducible |
1490 |
0.23 |
chr3_13035870_13036021 | 0.51 |
IQSEC1 |
IQ motif and Sec7 domain 1 |
7409 |
0.28 |
chr1_201437769_201437985 | 0.51 |
PHLDA3 |
pleckstrin homology-like domain, family A, member 3 |
435 |
0.8 |
chrX_135229876_135230073 | 0.51 |
FHL1 |
four and a half LIM domains 1 |
149 |
0.96 |
chr16_58549665_58549816 | 0.51 |
SETD6 |
SET domain containing 6 |
323 |
0.83 |
chr17_78194041_78194192 | 0.51 |
SGSH |
N-sulfoglucosamine sulfohydrolase |
16 |
0.59 |
chr6_83073756_83074156 | 0.51 |
TPBG |
trophoblast glycoprotein |
5 |
0.99 |
chr6_37023862_37024242 | 0.51 |
COX6A1P2 |
cytochrome c oxidase subunit VIa polypeptide 1 pseudogene 2 |
11445 |
0.2 |
chr2_96012022_96012173 | 0.51 |
KCNIP3 |
Kv channel interacting protein 3, calsenilin |
379 |
0.89 |
chr21_28338581_28338732 | 0.51 |
ADAMTS5 |
ADAM metallopeptidase with thrombospondin type 1 motif, 5 |
176 |
0.96 |
chr8_17434793_17434993 | 0.51 |
PDGFRL |
platelet-derived growth factor receptor-like |
192 |
0.96 |
chr8_95732220_95732371 | 0.51 |
DPY19L4 |
dpy-19-like 4 (C. elegans) |
167 |
0.95 |
chr20_2733232_2733444 | 0.50 |
EBF4 |
early B-cell factor 4 |
46451 |
0.08 |
chr10_111767466_111767617 | 0.50 |
ADD3 |
adducin 3 (gamma) |
179 |
0.95 |
chr17_74379047_74379198 | 0.50 |
SPHK1 |
sphingosine kinase 1 |
878 |
0.4 |
chr1_200708350_200708536 | 0.50 |
CAMSAP2 |
calmodulin regulated spectrin-associated protein family, member 2 |
243 |
0.95 |
chr9_38068078_38068353 | 0.50 |
SHB |
Src homology 2 domain containing adaptor protein B |
993 |
0.65 |
chr6_138724744_138725215 | 0.50 |
HEBP2 |
heme binding protein 2 |
311 |
0.91 |
chr9_132382514_132382665 | 0.50 |
C9orf50 |
chromosome 9 open reading frame 50 |
466 |
0.72 |
chr1_121138439_121138636 | 0.50 |
FCGR1B |
Fc fragment of IgG, high affinity Ib, receptor (CD64) |
202600 |
0.02 |
chr19_19143693_19143980 | 0.50 |
SUGP2 |
SURP and G patch domain containing 2 |
407 |
0.54 |
chr9_140009377_140009643 | 0.50 |
DPP7 |
dipeptidyl-peptidase 7 |
119 |
0.88 |
chr17_40020919_40021070 | 0.50 |
KLHL11 |
kelch-like family member 11 |
690 |
0.52 |
chr17_78428969_78429441 | 0.50 |
NPTX1 |
neuronal pentraxin I |
21199 |
0.14 |
chr9_88713610_88713943 | 0.50 |
GOLM1 |
golgi membrane protein 1 |
697 |
0.8 |
chr1_211751943_211752094 | 0.50 |
SLC30A1 |
solute carrier family 30 (zinc transporter), member 1 |
66 |
0.97 |
chr9_131182814_131182965 | 0.50 |
CERCAM |
cerebral endothelial cell adhesion molecule |
129 |
0.93 |
chr17_236054_236205 | 0.50 |
RPH3AL |
rabphilin 3A-like (without C2 domains) |
84 |
0.96 |
chr1_150039003_150039281 | 0.50 |
VPS45 |
vacuolar protein sorting 45 homolog (S. cerevisiae) |
227 |
0.92 |
chr12_58005256_58005449 | 0.49 |
ARHGEF25 |
Rho guanine nucleotide exchange factor (GEF) 25 |
134 |
0.9 |
chr5_136834825_136835025 | 0.49 |
SPOCK1 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 1 |
63 |
0.98 |
chr13_24153750_24153949 | 0.49 |
TNFRSF19 |
tumor necrosis factor receptor superfamily, member 19 |
330 |
0.93 |
chr17_1960797_1960948 | 0.49 |
HIC1 |
hypermethylated in cancer 1 |
1268 |
0.25 |
chr11_2320203_2320640 | 0.49 |
C11orf21 |
chromosome 11 open reading frame 21 |
2722 |
0.17 |
chr11_69458017_69458168 | 0.49 |
CCND1 |
cyclin D1 |
2118 |
0.35 |
chr18_5296007_5296158 | 0.49 |
ZBTB14 |
zinc finger and BTB domain containing 14 |
43 |
0.99 |
chr6_42419700_42419851 | 0.49 |
TRERF1 |
transcriptional regulating factor 1 |
8 |
0.98 |
chr1_241520319_241520674 | 0.49 |
RGS7 |
regulator of G-protein signaling 7 |
34 |
0.99 |
chr12_6876238_6876445 | 0.49 |
MLF2 |
myeloid leukemia factor 2 |
300 |
0.67 |
chr1_28586799_28587133 | 0.49 |
SESN2 |
sestrin 2 |
928 |
0.45 |
chr16_3014719_3014944 | 0.49 |
KREMEN2 |
kringle containing transmembrane protein 2 |
309 |
0.74 |
chr10_99259233_99259384 | 0.49 |
UBTD1 |
ubiquitin domain containing 1 |
683 |
0.4 |
chr4_149366140_149366291 | 0.49 |
NR3C2 |
nuclear receptor subfamily 3, group C, member 2 |
365 |
0.93 |
chr8_144349299_144349450 | 0.49 |
GLI4 |
GLI family zinc finger 4 |
233 |
0.87 |
chr9_139742830_139743087 | 0.48 |
PHPT1 |
phosphohistidine phosphatase 1 |
218 |
0.81 |
chr18_13137174_13137325 | 0.48 |
RP11-794M8.1 |
|
79075 |
0.08 |
chr1_212458972_212459123 | 0.48 |
PPP2R5A |
protein phosphatase 2, regulatory subunit B', alpha |
168 |
0.95 |
chr17_56234380_56234651 | 0.48 |
OR4D1 |
olfactory receptor, family 4, subfamily D, member 1 |
2021 |
0.25 |
chr14_102228690_102228847 | 0.48 |
PPP2R5C |
protein phosphatase 2, regulatory subunit B', gamma |
497 |
0.78 |
chr8_124553732_124553945 | 0.48 |
FBXO32 |
F-box protein 32 |
392 |
0.87 |
chr2_10263042_10263193 | 0.48 |
RRM2 |
ribonucleotide reductase M2 |
181 |
0.92 |
chr9_99212947_99213545 | 0.48 |
HABP4 |
hyaluronan binding protein 4 |
759 |
0.7 |
chr1_247274829_247274980 | 0.48 |
C1orf229 |
chromosome 1 open reading frame 229 |
815 |
0.57 |
chr3_32022334_32022485 | 0.48 |
OSBPL10 |
oxysterol binding protein-like 10 |
383 |
0.73 |
chr15_63796855_63797133 | 0.48 |
USP3 |
ubiquitin specific peptidase 3 |
139 |
0.97 |
chr2_55277190_55277482 | 0.48 |
RTN4 |
reticulon 4 |
100 |
0.97 |
chr17_78389255_78389406 | 0.48 |
ENDOV |
endonuclease V |
43 |
0.84 |
chr6_10417444_10417667 | 0.48 |
TFAP2A |
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) |
1132 |
0.45 |
chr5_1004838_1005013 | 0.48 |
ENSG00000221244 |
. |
623 |
0.63 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.8 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.6 | 1.8 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.6 | 1.7 | GO:0021825 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) substrate-dependent cerebral cortex tangential migration(GO:0021825) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.5 | 2.0 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.5 | 1.4 | GO:0072216 | positive regulation of metanephros development(GO:0072216) |
0.4 | 1.3 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.4 | 1.2 | GO:0002468 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) |
0.4 | 1.5 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.3 | 0.3 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
0.3 | 2.0 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.3 | 0.3 | GO:0048636 | positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
0.3 | 1.0 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.3 | 1.7 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.3 | 0.3 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.3 | 0.9 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.3 | 0.9 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.3 | 0.9 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.3 | 0.9 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.3 | 0.9 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.3 | 1.2 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
0.3 | 1.1 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.3 | 1.7 | GO:0001553 | luteinization(GO:0001553) |
0.3 | 0.6 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.3 | 0.6 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.3 | 0.8 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.3 | 0.8 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.3 | 0.8 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.3 | 1.4 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.3 | 1.1 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.3 | 0.8 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.3 | 0.8 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.3 | 0.5 | GO:0007172 | signal complex assembly(GO:0007172) |
0.3 | 0.8 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.3 | 0.5 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.3 | 0.8 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.3 | 0.3 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) peptidyl-histidine modification(GO:0018202) |
0.3 | 0.8 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.3 | 0.8 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.3 | 1.0 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.2 | 0.2 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.2 | 1.7 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.2 | 0.5 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.2 | 0.7 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.2 | 0.7 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.2 | 0.2 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.2 | 0.2 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.2 | 0.7 | GO:0046022 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.2 | 0.2 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.2 | 0.7 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.2 | 0.9 | GO:0018101 | protein citrullination(GO:0018101) |
0.2 | 1.1 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.2 | 0.2 | GO:0002887 | negative regulation of myeloid leukocyte mediated immunity(GO:0002887) negative regulation of leukocyte degranulation(GO:0043301) |
0.2 | 0.9 | GO:0022030 | cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) |
0.2 | 0.9 | GO:0003351 | epithelial cilium movement(GO:0003351) epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.2 | 1.1 | GO:0016322 | neuron remodeling(GO:0016322) |
0.2 | 0.9 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.2 | 1.1 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.2 | 1.5 | GO:0060363 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.2 | 1.1 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.2 | 0.4 | GO:0090192 | regulation of glomerulus development(GO:0090192) |
0.2 | 0.6 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
0.2 | 0.4 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.2 | 0.6 | GO:0010193 | response to ozone(GO:0010193) |
0.2 | 0.6 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.2 | 1.3 | GO:0034969 | histone arginine methylation(GO:0034969) |
0.2 | 0.2 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.2 | 0.2 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.2 | 0.8 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.2 | 1.0 | GO:0031062 | positive regulation of histone methylation(GO:0031062) |
0.2 | 1.0 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
0.2 | 0.4 | GO:0060736 | prostate gland growth(GO:0060736) |
0.2 | 0.2 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.2 | 0.2 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.2 | 0.4 | GO:0010761 | fibroblast migration(GO:0010761) |
0.2 | 0.6 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.2 | 0.6 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.2 | 0.4 | GO:0072131 | kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) |
0.2 | 1.2 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.2 | 0.6 | GO:0051451 | myoblast migration(GO:0051451) |
0.2 | 0.6 | GO:0001705 | ectoderm formation(GO:0001705) |
0.2 | 1.2 | GO:1903019 | negative regulation of glycoprotein metabolic process(GO:1903019) |
0.2 | 0.6 | GO:0001878 | response to yeast(GO:0001878) |
0.2 | 0.6 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.2 | 0.9 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.2 | 0.8 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.2 | 0.6 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.2 | 0.4 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.2 | 1.3 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.2 | 0.4 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.2 | 0.6 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.2 | 0.2 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.2 | 0.5 | GO:0019348 | polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
0.2 | 0.9 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.2 | 1.1 | GO:0060004 | reflex(GO:0060004) |
0.2 | 1.1 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.2 | 1.6 | GO:0010324 | phagocytosis, engulfment(GO:0006911) membrane invagination(GO:0010324) |
0.2 | 0.9 | GO:0006477 | protein sulfation(GO:0006477) |
0.2 | 0.3 | GO:0002407 | dendritic cell chemotaxis(GO:0002407) dendritic cell migration(GO:0036336) |
0.2 | 0.5 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.2 | 0.7 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.2 | 0.7 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.2 | 0.3 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.2 | 0.5 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.2 | 0.3 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.2 | 0.5 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.2 | 1.0 | GO:0031274 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.2 | 0.2 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.2 | 0.5 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.2 | 1.0 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.2 | 0.5 | GO:0035583 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.2 | 1.7 | GO:0045749 | obsolete negative regulation of S phase of mitotic cell cycle(GO:0045749) |
0.2 | 0.3 | GO:0001821 | histamine secretion(GO:0001821) |
0.2 | 0.2 | GO:0002248 | wound healing involved in inflammatory response(GO:0002246) connective tissue replacement involved in inflammatory response wound healing(GO:0002248) inflammatory response to wounding(GO:0090594) connective tissue replacement(GO:0097709) |
0.2 | 0.8 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.2 | 0.3 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.2 | 0.3 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.2 | 1.3 | GO:0046348 | amino sugar catabolic process(GO:0046348) glucosamine-containing compound catabolic process(GO:1901072) |
0.2 | 0.3 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.2 | 0.2 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.2 | 1.3 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.2 | 0.5 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.2 | 0.6 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.2 | 0.2 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.2 | 0.3 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.2 | 0.3 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.2 | 0.5 | GO:0060596 | mammary placode formation(GO:0060596) |
0.2 | 0.3 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.2 | 0.5 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.2 | 0.6 | GO:0060088 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.2 | 0.5 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.2 | 0.5 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.2 | 0.5 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) protein side chain deglutamylation(GO:0035610) |
0.2 | 0.5 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.2 | 0.2 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.2 | 0.5 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.2 | 0.5 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.2 | 0.2 | GO:0001845 | phagolysosome assembly(GO:0001845) phagosome maturation(GO:0090382) |
0.2 | 0.3 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.2 | 0.3 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.2 | 0.2 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.1 | 0.4 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.6 | GO:0031297 | replication fork processing(GO:0031297) |
0.1 | 0.3 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.1 | 1.2 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.1 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 1.2 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.1 | 0.4 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
0.1 | 1.0 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.1 | 0.9 | GO:0009103 | lipopolysaccharide biosynthetic process(GO:0009103) |
0.1 | 0.7 | GO:0042634 | regulation of hair cycle(GO:0042634) |
0.1 | 0.4 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.1 | 0.4 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.1 | 1.3 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 1.3 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 0.3 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.1 | 0.7 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.1 | 0.6 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.3 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.1 | 0.3 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.1 | 0.7 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.1 | 0.8 | GO:0035510 | DNA dealkylation(GO:0035510) |
0.1 | 1.1 | GO:0051319 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.1 | 0.3 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.1 | 0.1 | GO:0014897 | cardiac muscle hypertrophy(GO:0003300) striated muscle hypertrophy(GO:0014897) |
0.1 | 0.3 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
0.1 | 0.3 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.1 | 0.3 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 1.2 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
0.1 | 0.8 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.3 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.1 | 0.3 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.1 | 0.7 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 1.1 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.1 | 0.7 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.1 | 0.1 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.1 | 0.4 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
0.1 | 0.3 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.1 | 0.8 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.1 | 0.4 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.1 | 0.3 | GO:0090047 | obsolete positive regulation of transcription regulator activity(GO:0090047) |
0.1 | 0.3 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.1 | 0.3 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.1 | 0.5 | GO:0045655 | regulation of monocyte differentiation(GO:0045655) |
0.1 | 0.4 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 0.1 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.1 | 0.4 | GO:0014009 | glial cell proliferation(GO:0014009) |
0.1 | 0.8 | GO:0031650 | regulation of fever generation(GO:0031620) positive regulation of fever generation(GO:0031622) regulation of heat generation(GO:0031650) positive regulation of heat generation(GO:0031652) |
0.1 | 0.4 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 0.1 | GO:0060510 | lung saccule development(GO:0060430) Type II pneumocyte differentiation(GO:0060510) |
0.1 | 0.1 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 3.5 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
0.1 | 0.4 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 0.3 | GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.1 | 0.9 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.1 | 0.4 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.1 | 0.5 | GO:0061726 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
0.1 | 0.4 | GO:0008347 | glial cell migration(GO:0008347) |
0.1 | 0.4 | GO:0035930 | corticosteroid hormone secretion(GO:0035930) regulation of steroid hormone secretion(GO:2000831) regulation of corticosteroid hormone secretion(GO:2000846) |
0.1 | 0.4 | GO:0021799 | cerebral cortex radially oriented cell migration(GO:0021799) |
0.1 | 0.4 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.1 | 0.6 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.1 | 0.2 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.1 | 1.9 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 0.5 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 0.4 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.1 | 0.4 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 0.9 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.1 | 0.2 | GO:0042640 | anagen(GO:0042640) |
0.1 | 0.4 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.1 | GO:0002363 | alpha-beta T cell lineage commitment(GO:0002363) |
0.1 | 0.4 | GO:0071501 | SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.1 | 0.2 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.1 | 0.1 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.1 | 0.4 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.1 | 0.5 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.1 | 0.2 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.1 | 0.2 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.1 | 0.5 | GO:0008218 | bioluminescence(GO:0008218) |
0.1 | 0.2 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.1 | 0.5 | GO:0010288 | response to lead ion(GO:0010288) |
0.1 | 0.3 | GO:1903313 | positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.1 | 0.2 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.1 | 0.6 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.1 | 0.7 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.1 | 0.3 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.1 | 0.2 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.6 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
0.1 | 0.6 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.1 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.1 | 0.5 | GO:0019228 | neuronal action potential(GO:0019228) |
0.1 | 0.3 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.1 | 0.1 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.1 | 0.3 | GO:0035121 | obsolete tail morphogenesis(GO:0035121) |
0.1 | 0.2 | GO:0007051 | spindle organization(GO:0007051) |
0.1 | 0.2 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.1 | 0.3 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.1 | 0.8 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.1 | 0.2 | GO:0010755 | regulation of plasminogen activation(GO:0010755) |
0.1 | 0.6 | GO:1901797 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.1 | 0.6 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.1 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.1 | 0.4 | GO:0017085 | response to insecticide(GO:0017085) |
0.1 | 0.4 | GO:0045429 | positive regulation of nitric oxide biosynthetic process(GO:0045429) positive regulation of reactive oxygen species biosynthetic process(GO:1903428) positive regulation of nitric oxide metabolic process(GO:1904407) |
0.1 | 0.3 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 0.4 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.1 | 0.2 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.1 | 0.3 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.1 | 0.1 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.1 | 0.3 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.1 | 0.4 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.1 | 0.1 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.1 | 0.9 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.1 | GO:0048570 | notochord morphogenesis(GO:0048570) |
0.1 | 0.6 | GO:0032528 | microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
0.1 | 0.6 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.1 | 0.1 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.1 | 0.4 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.1 | 0.1 | GO:0015809 | arginine transport(GO:0015809) |
0.1 | 0.8 | GO:0046885 | regulation of hormone biosynthetic process(GO:0046885) |
0.1 | 0.4 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
0.1 | 0.2 | GO:0010587 | miRNA metabolic process(GO:0010586) miRNA catabolic process(GO:0010587) |
0.1 | 1.5 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.1 | 0.2 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
0.1 | 1.3 | GO:0015858 | nucleoside transport(GO:0015858) |
0.1 | 0.2 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.1 | 0.3 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.1 | 0.4 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.2 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.1 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.1 | 0.1 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.1 | 0.2 | GO:0046033 | AMP metabolic process(GO:0046033) |
0.1 | 0.4 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.1 | 0.1 | GO:1904031 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.1 | 0.3 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 0.2 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.1 | 0.2 | GO:2001234 | negative regulation of mitochondrion organization(GO:0010823) negative regulation of release of cytochrome c from mitochondria(GO:0090201) negative regulation of apoptotic signaling pathway(GO:2001234) |
0.1 | 0.4 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.2 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.1 | 0.3 | GO:0032967 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of collagen biosynthetic process(GO:0032967) positive regulation of multicellular organismal metabolic process(GO:0044253) |
0.1 | 0.3 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.3 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.1 | 0.4 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.1 | 0.7 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.1 | 0.5 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.1 | 0.4 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) |
0.1 | 0.4 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.1 | 0.1 | GO:0048548 | regulation of pinocytosis(GO:0048548) |
0.1 | 0.6 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.1 | 0.5 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.1 | 0.1 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
0.1 | 0.4 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.1 | 0.7 | GO:0043545 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.3 | GO:0002063 | chondrocyte development(GO:0002063) |
0.1 | 0.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.4 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.1 | 0.2 | GO:0034204 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.1 | 0.3 | GO:0097035 | phospholipid scrambling(GO:0017121) regulation of membrane lipid distribution(GO:0097035) |
0.1 | 0.6 | GO:0097384 | cellular lipid biosynthetic process(GO:0097384) |
0.1 | 0.8 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.1 | 0.1 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
0.1 | 0.4 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.5 | GO:0007549 | dosage compensation(GO:0007549) |
0.1 | 0.8 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 1.1 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 0.4 | GO:0015811 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.1 | 0.3 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.1 | 0.2 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.1 | 0.3 | GO:0051322 | anaphase(GO:0051322) |
0.1 | 0.3 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.1 | 0.7 | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
0.1 | 0.6 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.1 | 0.1 | GO:0015802 | basic amino acid transport(GO:0015802) |
0.1 | 0.2 | GO:1901796 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) regulation of signal transduction by p53 class mediator(GO:1901796) |
0.1 | 0.3 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.1 | 0.3 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.1 | 0.2 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 0.4 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.1 | 1.4 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) cellular response to unfolded protein(GO:0034620) |
0.1 | 0.2 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.1 | 0.9 | GO:0033189 | response to vitamin A(GO:0033189) |
0.1 | 0.6 | GO:0031000 | response to caffeine(GO:0031000) |
0.1 | 0.1 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.1 | 0.4 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.1 | 0.8 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.4 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.7 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.1 | 0.2 | GO:0052166 | pathogen-associated molecular pattern dependent induction by symbiont of host innate immune response(GO:0052033) positive regulation by symbiont of host innate immune response(GO:0052166) modulation by symbiont of host innate immune response(GO:0052167) pathogen-associated molecular pattern dependent modulation by symbiont of host innate immune response(GO:0052169) pathogen-associated molecular pattern dependent induction by organism of innate immune response of other organism involved in symbiotic interaction(GO:0052257) positive regulation by organism of innate immune response in other organism involved in symbiotic interaction(GO:0052305) modulation by organism of innate immune response in other organism involved in symbiotic interaction(GO:0052306) pathogen-associated molecular pattern dependent modulation by organism of innate immune response in other organism involved in symbiotic interaction(GO:0052308) |
0.1 | 0.6 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.1 | 0.3 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 0.4 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 0.5 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.1 | 0.3 | GO:0072583 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.1 | 0.6 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.1 | 0.5 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.4 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.1 | 0.3 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.1 | 0.2 | GO:1903960 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) negative regulation of anion transmembrane transport(GO:1903960) negative regulation of fatty acid transport(GO:2000192) |
0.1 | 0.2 | GO:1904019 | endothelial cell apoptotic process(GO:0072577) epithelial cell apoptotic process(GO:1904019) regulation of epithelial cell apoptotic process(GO:1904035) regulation of endothelial cell apoptotic process(GO:2000351) |
0.1 | 0.3 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.4 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.1 | 0.8 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.1 | 0.6 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.9 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 0.3 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.1 | 0.4 | GO:0046618 | drug export(GO:0046618) |
0.1 | 0.1 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.1 | 0.5 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.1 | 0.3 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.1 | 0.7 | GO:0006241 | GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) UTP metabolic process(GO:0046051) |
0.1 | 1.2 | GO:0046134 | pyrimidine nucleoside biosynthetic process(GO:0046134) |
0.1 | 0.2 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.1 | 0.4 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.1 | 0.3 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 0.1 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.6 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 0.3 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.1 | 0.3 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.1 | 0.2 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
0.1 | 0.4 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.1 | 0.4 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
0.1 | 0.4 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.1 | 0.3 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.1 | 0.2 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.1 | 0.2 | GO:0071436 | sodium ion export(GO:0071436) |
0.1 | 0.1 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.1 | 0.1 | GO:0003057 | regulation of the force of heart contraction by chemical signal(GO:0003057) |
0.1 | 0.6 | GO:0034311 | diol metabolic process(GO:0034311) |
0.1 | 0.3 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.3 | GO:0045006 | DNA deamination(GO:0045006) |
0.1 | 0.3 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.1 | 0.6 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
0.1 | 0.7 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.1 | 0.3 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.1 | 0.3 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.2 | GO:0010159 | specification of organ position(GO:0010159) |
0.1 | 0.1 | GO:0043931 | ossification involved in bone maturation(GO:0043931) |
0.1 | 0.3 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 0.3 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.1 | 0.7 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.1 | 0.3 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 1.0 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.2 | GO:0006562 | proline catabolic process(GO:0006562) |
0.1 | 0.3 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.1 | 2.0 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 0.1 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
0.1 | 0.1 | GO:0045910 | negative regulation of DNA recombination(GO:0045910) |
0.1 | 0.7 | GO:1901071 | glucosamine-containing compound metabolic process(GO:1901071) |
0.1 | 0.2 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) |
0.1 | 0.3 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.1 | 0.3 | GO:0021898 | forebrain neuron fate commitment(GO:0021877) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.1 | 0.3 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 1.1 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
0.1 | 0.3 | GO:0000239 | pachytene(GO:0000239) |
0.1 | 0.2 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.1 | 0.7 | GO:0051923 | sulfation(GO:0051923) |
0.1 | 0.2 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.1 | 0.7 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) COPII-coated vesicle budding(GO:0090114) |
0.1 | 0.2 | GO:0016571 | histone methylation(GO:0016571) |
0.1 | 0.5 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.2 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.1 | 0.2 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.1 | 0.2 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.1 | 0.1 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.1 | 0.4 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 0.5 | GO:0007128 | meiotic prophase I(GO:0007128) |
0.1 | 0.3 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.1 | 0.1 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.1 | 0.2 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 0.1 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.1 | 0.2 | GO:0042102 | positive regulation of T cell proliferation(GO:0042102) |
0.1 | 0.2 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
0.1 | 0.1 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.1 | 0.5 | GO:0043122 | regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043122) |
0.1 | 1.6 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.2 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.1 | 0.2 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.1 | 0.8 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.1 | 0.1 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.4 | GO:0072384 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) organelle transport along microtubule(GO:0072384) |
0.1 | 0.2 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.1 | 0.9 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.1 | 0.2 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 0.3 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 0.9 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.1 | 0.2 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) protein localization to microtubule cytoskeleton(GO:0072698) |
0.1 | 0.2 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.1 | 0.1 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
0.1 | 0.4 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.1 | 0.2 | GO:0051894 | positive regulation of focal adhesion assembly(GO:0051894) positive regulation of cell junction assembly(GO:1901890) positive regulation of adherens junction organization(GO:1903393) |
0.1 | 0.1 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.1 | 3.0 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.1 | 0.7 | GO:0007520 | myoblast fusion(GO:0007520) |
0.1 | 0.2 | GO:0022038 | corpus callosum development(GO:0022038) |
0.1 | 0.3 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.1 | 0.3 | GO:0002329 | immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) |
0.1 | 1.2 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.1 | 0.3 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.1 | 0.4 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 0.5 | GO:0047496 | vesicle transport along microtubule(GO:0047496) vesicle cytoskeletal trafficking(GO:0099518) |
0.1 | 0.1 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.1 | 0.3 | GO:0010611 | regulation of cardiac muscle hypertrophy(GO:0010611) |
0.1 | 0.1 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.1 | 0.2 | GO:0021754 | facial nucleus development(GO:0021754) |
0.1 | 0.1 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) positive regulation of cell cycle checkpoint(GO:1901978) regulation of mitotic spindle checkpoint(GO:1903504) |
0.1 | 0.3 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.1 | 0.1 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.1 | 0.1 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.1 | 0.1 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
0.1 | 0.1 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.1 | 1.3 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 0.1 | GO:0001865 | NK T cell differentiation(GO:0001865) tolerance induction to self antigen(GO:0002513) regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.1 | 0.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.6 | GO:0019915 | lipid storage(GO:0019915) |
0.1 | 0.9 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.3 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.1 | 0.1 | GO:0060437 | lung growth(GO:0060437) |
0.1 | 0.7 | GO:0051983 | regulation of chromosome segregation(GO:0051983) |
0.1 | 0.1 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.1 | 0.1 | GO:0033866 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.1 | 0.5 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.1 | 0.3 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.4 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.1 | 1.2 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.1 | 0.3 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 0.6 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.1 | 0.6 | GO:0007379 | segment specification(GO:0007379) |
0.1 | 0.3 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.1 | 0.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 0.4 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.1 | GO:0017014 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.1 | 0.1 | GO:0032042 | mitochondrial DNA metabolic process(GO:0032042) |
0.1 | 0.6 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.1 | 0.1 | GO:0070875 | positive regulation of glycogen biosynthetic process(GO:0045725) positive regulation of glycogen metabolic process(GO:0070875) |
0.1 | 0.2 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.1 | 0.1 | GO:0015780 | nucleotide-sugar transport(GO:0015780) |
0.1 | 0.6 | GO:0032456 | endocytic recycling(GO:0032456) |
0.1 | 0.1 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.1 | 0.3 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 0.3 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.2 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.1 | 0.2 | GO:0001880 | Mullerian duct regression(GO:0001880) anatomical structure regression(GO:0060033) |
0.1 | 0.1 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.1 | 0.1 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.1 | 0.5 | GO:0015791 | polyol transport(GO:0015791) |
0.1 | 0.1 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.1 | 1.0 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.1 | 0.3 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.1 | GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway(GO:0090081) |
0.1 | 0.1 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.1 | 0.2 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.1 | 0.1 | GO:1902743 | regulation of lamellipodium organization(GO:1902743) |
0.1 | 0.1 | GO:0048541 | Peyer's patch development(GO:0048541) |
0.1 | 0.5 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.9 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.3 | GO:0001881 | receptor recycling(GO:0001881) |
0.1 | 0.1 | GO:0051324 | prophase(GO:0051324) |
0.1 | 0.1 | GO:0051873 | disruption of cells of other organism involved in symbiotic interaction(GO:0051818) disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) killing of cells in other organism involved in symbiotic interaction(GO:0051883) |
0.1 | 0.1 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.1 | 1.1 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.1 | 0.1 | GO:0032367 | intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
0.1 | 0.5 | GO:0006554 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.1 | 0.3 | GO:0006388 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.1 | 0.3 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 0.7 | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
0.1 | 0.3 | GO:0031498 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.1 | 0.3 | GO:0071514 | genetic imprinting(GO:0071514) |
0.1 | 0.2 | GO:1903299 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 0.4 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
0.1 | 0.6 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.1 | 0.1 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 0.4 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.1 | 0.3 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 1.7 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 0.6 | GO:0006386 | transcription elongation from RNA polymerase III promoter(GO:0006385) termination of RNA polymerase III transcription(GO:0006386) |
0.1 | 0.4 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.1 | 0.4 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.1 | 0.1 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 0.8 | GO:0030032 | lamellipodium assembly(GO:0030032) lamellipodium organization(GO:0097581) |
0.1 | 0.3 | GO:0042992 | negative regulation of transcription factor import into nucleus(GO:0042992) |
0.1 | 0.4 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.1 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
0.1 | 0.4 | GO:0007041 | lysosomal transport(GO:0007041) |
0.1 | 0.2 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.1 | 1.2 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.1 | 0.2 | GO:0060045 | positive regulation of cardiac muscle tissue growth(GO:0055023) positive regulation of cardiac muscle tissue development(GO:0055025) positive regulation of cardiac muscle cell proliferation(GO:0060045) |
0.1 | 0.2 | GO:0031641 | regulation of myelination(GO:0031641) |
0.1 | 0.2 | GO:0090037 | regulation of protein kinase C signaling(GO:0090036) positive regulation of protein kinase C signaling(GO:0090037) |
0.1 | 0.1 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 0.1 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.2 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) cell death in response to oxidative stress(GO:0036473) |
0.1 | 0.4 | GO:0042401 | cellular biogenic amine biosynthetic process(GO:0042401) |
0.1 | 0.2 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.2 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.1 | 0.4 | GO:1902749 | regulation of G2/M transition of mitotic cell cycle(GO:0010389) regulation of cell cycle G2/M phase transition(GO:1902749) |
0.1 | 0.1 | GO:0051000 | positive regulation of nitric-oxide synthase activity(GO:0051000) |
0.1 | 0.9 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 0.2 | GO:0030903 | notochord development(GO:0030903) |
0.1 | 0.2 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.1 | 0.4 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.9 | GO:0044743 | intracellular protein transmembrane import(GO:0044743) |
0.1 | 0.1 | GO:0046469 | platelet activating factor metabolic process(GO:0046469) |
0.1 | 1.0 | GO:0006400 | tRNA modification(GO:0006400) |
0.1 | 0.4 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.1 | 0.2 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.1 | 0.9 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.1 | 0.5 | GO:0010165 | response to X-ray(GO:0010165) |
0.1 | 0.3 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.1 | 0.4 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.1 | 0.1 | GO:0046931 | pore complex assembly(GO:0046931) |
0.1 | 0.1 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.8 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 0.2 | GO:0032506 | cytokinetic process(GO:0032506) |
0.1 | 0.1 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.1 | 0.5 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
0.1 | 0.1 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.1 | 0.1 | GO:2001233 | regulation of release of cytochrome c from mitochondria(GO:0090199) regulation of apoptotic signaling pathway(GO:2001233) |
0.1 | 0.4 | GO:0007567 | parturition(GO:0007567) |
0.1 | 0.2 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.1 | 0.1 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.1 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.1 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.1 | 0.8 | GO:0008633 | obsolete activation of pro-apoptotic gene products(GO:0008633) |
0.1 | 0.3 | GO:0006972 | hyperosmotic response(GO:0006972) |
0.1 | 0.3 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.1 | 0.1 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.1 | 0.2 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.1 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
0.1 | 0.2 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.1 | 0.3 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.1 | GO:0006565 | L-serine catabolic process(GO:0006565) |
0.1 | 0.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.2 | GO:0000718 | nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) |
0.1 | 0.2 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.1 | 0.3 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.1 | 0.1 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 0.3 | GO:0050999 | regulation of nitric-oxide synthase activity(GO:0050999) |
0.1 | 0.7 | GO:0046677 | response to antibiotic(GO:0046677) |
0.1 | 0.2 | GO:0000154 | rRNA modification(GO:0000154) |
0.1 | 0.2 | GO:0009191 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
0.1 | 0.7 | GO:1902579 | multi-organism transport(GO:0044766) transport of virus(GO:0046794) intracellular transport of virus(GO:0075733) multi-organism localization(GO:1902579) multi-organism intracellular transport(GO:1902583) |
0.1 | 0.2 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.1 | 0.2 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
0.1 | 0.3 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.1 | 0.3 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.1 | 0.2 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.1 | 0.4 | GO:0006895 | Golgi to endosome transport(GO:0006895) Golgi to vacuole transport(GO:0006896) |
0.1 | 0.1 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.1 | 0.2 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
0.1 | 0.2 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 1.0 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.2 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.1 | 0.4 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.1 | 0.2 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.3 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.1 | 0.2 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.1 | 1.0 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.1 | 0.1 | GO:0033692 | cellular polysaccharide biosynthetic process(GO:0033692) |
0.1 | 0.2 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.1 | 0.1 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.1 | 0.1 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.1 | 0.6 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.1 | 0.6 | GO:0018200 | peptidyl-glutamic acid modification(GO:0018200) |
0.1 | 0.4 | GO:0006098 | pentose-phosphate shunt(GO:0006098) glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.1 | 0.4 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.1 | 0.4 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.1 | 0.3 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.1 | 0.1 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.1 | 0.1 | GO:0044247 | polysaccharide catabolic process(GO:0000272) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.1 | 0.1 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 0.1 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.1 | 0.3 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.1 | 0.1 | GO:0014066 | regulation of phosphatidylinositol 3-kinase signaling(GO:0014066) |
0.1 | 0.1 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 0.1 | GO:0051299 | centrosome separation(GO:0051299) |
0.1 | 0.6 | GO:0050850 | positive regulation of calcium-mediated signaling(GO:0050850) |
0.1 | 0.4 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.1 | 0.2 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.1 | 0.3 | GO:0032816 | positive regulation of natural killer cell activation(GO:0032816) |
0.1 | 0.2 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.1 | 0.1 | GO:0002634 | regulation of germinal center formation(GO:0002634) |
0.1 | 0.3 | GO:0006743 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
0.1 | 0.2 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 0.3 | GO:0030641 | regulation of cellular pH(GO:0030641) |
0.1 | 0.1 | GO:0010470 | regulation of gastrulation(GO:0010470) |
0.1 | 0.2 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 6.3 | GO:0016311 | dephosphorylation(GO:0016311) |
0.1 | 0.4 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.1 | 0.2 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.1 | 0.4 | GO:0048015 | phosphatidylinositol-mediated signaling(GO:0048015) inositol lipid-mediated signaling(GO:0048017) |
0.1 | 0.1 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
0.1 | 0.1 | GO:0009215 | purine deoxyribonucleoside triphosphate metabolic process(GO:0009215) |
0.0 | 0.6 | GO:0030593 | neutrophil chemotaxis(GO:0030593) neutrophil migration(GO:1990266) |
0.0 | 0.1 | GO:0032735 | positive regulation of interleukin-12 production(GO:0032735) |
0.0 | 0.9 | GO:0006413 | translational initiation(GO:0006413) |
0.0 | 0.1 | GO:0032288 | myelin assembly(GO:0032288) |
0.0 | 0.1 | GO:0032091 | negative regulation of protein binding(GO:0032091) |
0.0 | 0.2 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.2 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.0 | 3.1 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.0 | 0.3 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.0 | 2.1 | GO:0006402 | mRNA catabolic process(GO:0006402) |
0.0 | 0.1 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.0 | 0.0 | GO:0042117 | monocyte activation(GO:0042117) |
0.0 | 0.1 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.0 | 0.1 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 0.1 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.0 | 0.1 | GO:0042762 | regulation of sulfur metabolic process(GO:0042762) |
0.0 | 0.6 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.0 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.0 | 0.0 | GO:0014041 | regulation of neuron maturation(GO:0014041) regulation of cell maturation(GO:1903429) |
0.0 | 1.7 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
0.0 | 0.2 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 1.3 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.0 | 0.2 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.0 | 0.2 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.0 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) detection of bacterial lipopeptide(GO:0070340) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.5 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
0.0 | 1.3 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.0 | 2.5 | GO:0009206 | ribonucleoside triphosphate biosynthetic process(GO:0009201) purine ribonucleoside triphosphate biosynthetic process(GO:0009206) |
0.0 | 0.1 | GO:0009750 | response to fructose(GO:0009750) |
0.0 | 2.2 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.0 | 0.0 | GO:0009145 | purine nucleoside triphosphate biosynthetic process(GO:0009145) |
0.0 | 0.0 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.0 | 0.2 | GO:0010039 | response to iron ion(GO:0010039) |
0.0 | 0.0 | GO:0070301 | cellular response to hydrogen peroxide(GO:0070301) |
0.0 | 0.3 | GO:0031100 | organ regeneration(GO:0031100) |
0.0 | 0.3 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
0.0 | 0.4 | GO:0031929 | TOR signaling(GO:0031929) |
0.0 | 0.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.1 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 1.7 | GO:0006914 | autophagy(GO:0006914) |
0.0 | 0.0 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.0 | 0.0 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.0 | 0.5 | GO:0033574 | response to testosterone(GO:0033574) |
0.0 | 0.2 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.5 | GO:0071554 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.0 | 0.1 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.0 | 1.2 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.0 | 0.5 | GO:0097193 | intrinsic apoptotic signaling pathway(GO:0097193) |
0.0 | 0.0 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.0 | 0.7 | GO:0006094 | gluconeogenesis(GO:0006094) |
0.0 | 0.1 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.0 | 0.1 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.0 | 0.1 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.0 | 0.1 | GO:0060325 | face morphogenesis(GO:0060325) |
0.0 | 0.1 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.0 | 0.3 | GO:0045730 | respiratory burst(GO:0045730) |
0.0 | 0.0 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.0 | 0.6 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
0.0 | 0.7 | GO:0006469 | negative regulation of protein kinase activity(GO:0006469) |
0.0 | 0.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.1 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.4 | GO:0046503 | glycerolipid catabolic process(GO:0046503) |
0.0 | 0.5 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.1 | GO:0070972 | protein localization to endoplasmic reticulum(GO:0070972) |
0.0 | 0.6 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.0 | 0.1 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.0 | 0.2 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.0 | 0.3 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.0 | 5.1 | GO:0000398 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
0.0 | 0.0 | GO:0052564 | response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) |
0.0 | 0.2 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 0.2 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.0 | 0.2 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.0 | 0.1 | GO:0060438 | trachea development(GO:0060438) |
0.0 | 0.1 | GO:0008064 | regulation of actin polymerization or depolymerization(GO:0008064) |
0.0 | 0.1 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.1 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
0.0 | 0.2 | GO:0090303 | positive regulation of wound healing(GO:0090303) |
0.0 | 0.1 | GO:0009648 | photoperiodism(GO:0009648) |
0.0 | 0.0 | GO:0071223 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.0 | 0.2 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.0 | 0.1 | GO:0033158 | regulation of protein import into nucleus, translocation(GO:0033158) |
0.0 | 2.2 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.0 | 0.1 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.0 | 0.4 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.0 | 0.5 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.0 | 0.5 | GO:0018904 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.0 | 0.0 | GO:0031529 | ruffle organization(GO:0031529) |
0.0 | 0.1 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.4 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.0 | 0.2 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.0 | GO:0006595 | polyamine metabolic process(GO:0006595) |
0.0 | 0.3 | GO:0007032 | endosome organization(GO:0007032) |
0.0 | 1.6 | GO:0000236 | mitotic prometaphase(GO:0000236) |
0.0 | 0.2 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.0 | 0.2 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
0.0 | 0.3 | GO:0042255 | ribosome assembly(GO:0042255) |
0.0 | 0.4 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) positive regulation of proteasomal protein catabolic process(GO:1901800) |
0.0 | 0.1 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.0 | GO:0045862 | positive regulation of proteolysis(GO:0045862) |
0.0 | 0.6 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.0 | 0.1 | GO:0051904 | melanosome transport(GO:0032402) pigment granule transport(GO:0051904) |
0.0 | 0.1 | GO:0045732 | positive regulation of protein catabolic process(GO:0045732) |
0.0 | 0.2 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
0.0 | 0.1 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.0 | 0.1 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.0 | 0.4 | GO:0006298 | mismatch repair(GO:0006298) |
0.0 | 0.0 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.0 | 0.1 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.0 | 0.0 | GO:0010821 | regulation of mitochondrion organization(GO:0010821) |
0.0 | 0.5 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.0 | 0.0 | GO:0070230 | positive regulation of lymphocyte apoptotic process(GO:0070230) |
0.0 | 0.5 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.0 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.0 | 0.1 | GO:0031638 | zymogen activation(GO:0031638) |
0.0 | 0.2 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.1 | GO:0008228 | opsonization(GO:0008228) |
0.0 | 0.5 | GO:0051225 | spindle assembly(GO:0051225) |
0.0 | 0.1 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.0 | 0.1 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.0 | 0.1 | GO:0006862 | nucleotide transport(GO:0006862) |
0.0 | 2.2 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.0 | 0.1 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.1 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.1 | GO:0065004 | protein-DNA complex assembly(GO:0065004) |
0.0 | 0.1 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.0 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
0.0 | 0.0 | GO:0045010 | actin nucleation(GO:0045010) |
0.0 | 0.2 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.0 | 0.1 | GO:0000959 | mitochondrial RNA metabolic process(GO:0000959) transcription from mitochondrial promoter(GO:0006390) |
0.0 | 1.2 | GO:0034339 | obsolete regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor(GO:0034339) |
0.0 | 0.8 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
0.0 | 0.4 | GO:0019079 | viral genome replication(GO:0019079) |
0.0 | 0.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 1.2 | GO:0043039 | tRNA aminoacylation for protein translation(GO:0006418) amino acid activation(GO:0043038) tRNA aminoacylation(GO:0043039) |
0.0 | 0.2 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.0 | 1.6 | GO:0000086 | G2/M transition of mitotic cell cycle(GO:0000086) cell cycle G2/M phase transition(GO:0044839) |
0.0 | 0.1 | GO:0071456 | cellular response to decreased oxygen levels(GO:0036294) cellular response to oxygen levels(GO:0071453) cellular response to hypoxia(GO:0071456) |
0.0 | 0.5 | GO:0006401 | RNA catabolic process(GO:0006401) |
0.0 | 0.4 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.0 | 0.1 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.0 | 0.0 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
0.0 | 0.1 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.0 | 0.0 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) negative regulation of protein export from nucleus(GO:0046826) negative regulation of mRNA processing(GO:0050686) negative regulation of mRNA metabolic process(GO:1903312) |
0.0 | 0.0 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.0 | 0.2 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.0 | 0.2 | GO:0019359 | NAD biosynthetic process(GO:0009435) nicotinamide nucleotide biosynthetic process(GO:0019359) |
0.0 | 0.3 | GO:0050832 | defense response to fungus(GO:0050832) |
0.0 | 0.1 | GO:0051642 | centrosome localization(GO:0051642) |
0.0 | 1.3 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.0 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.0 | 3.3 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.0 | 0.1 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.0 | 0.4 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.0 | 0.1 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.0 | 1.9 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.0 | 0.2 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.0 | 0.1 | GO:0043526 | obsolete neuroprotection(GO:0043526) |
0.0 | 0.0 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.0 | 0.2 | GO:0042730 | fibrinolysis(GO:0042730) |
0.0 | 0.4 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 0.6 | GO:0006081 | cellular aldehyde metabolic process(GO:0006081) |
0.0 | 0.0 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.1 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.0 | 0.1 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.0 | 0.0 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.0 | 0.0 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.0 | 0.1 | GO:0042752 | regulation of circadian rhythm(GO:0042752) |
0.0 | 0.4 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.1 | GO:0005977 | glycogen metabolic process(GO:0005977) |
0.0 | 0.0 | GO:0001302 | replicative cell aging(GO:0001302) |
0.0 | 0.0 | GO:0070254 | mucus secretion(GO:0070254) |
0.0 | 0.2 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.0 | 1.0 | GO:0016197 | endosomal transport(GO:0016197) |
0.0 | 0.1 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.0 | 0.0 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.0 | 0.2 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.0 | 0.0 | GO:0060324 | face development(GO:0060324) |
0.0 | 0.1 | GO:0045123 | cellular extravasation(GO:0045123) |
0.0 | 0.4 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.0 | 1.1 | GO:0006826 | iron ion transport(GO:0006826) |
0.0 | 0.0 | GO:0051900 | regulation of mitochondrial depolarization(GO:0051900) |
0.0 | 0.7 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 0.4 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.5 | GO:0043401 | steroid hormone mediated signaling pathway(GO:0043401) |
0.0 | 1.0 | GO:0008033 | tRNA processing(GO:0008033) |
0.0 | 0.1 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.0 | 0.0 | GO:0072033 | renal vesicle formation(GO:0072033) |
0.0 | 0.2 | GO:0015695 | organic cation transport(GO:0015695) |
0.0 | 0.5 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 3.1 | GO:0006281 | DNA repair(GO:0006281) |
0.0 | 0.1 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.0 | 0.0 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.0 | 0.2 | GO:0055072 | iron ion homeostasis(GO:0055072) |
0.0 | 0.1 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.0 | 0.1 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.0 | 0.1 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.0 | 0.0 | GO:0001832 | blastocyst growth(GO:0001832) |
0.0 | 0.1 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.0 | 0.1 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.0 | 0.1 | GO:0071333 | cellular response to carbohydrate stimulus(GO:0071322) cellular response to monosaccharide stimulus(GO:0071326) cellular response to hexose stimulus(GO:0071331) cellular response to glucose stimulus(GO:0071333) |
0.0 | 0.1 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.1 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.0 | 0.2 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.2 | GO:0051320 | mitotic S phase(GO:0000084) S phase(GO:0051320) |
0.0 | 0.0 | GO:0071478 | cellular response to radiation(GO:0071478) |
0.0 | 0.1 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.2 | GO:0001676 | long-chain fatty acid metabolic process(GO:0001676) |
0.0 | 0.1 | GO:0051181 | cofactor transport(GO:0051181) |
0.0 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.1 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
0.0 | 0.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.0 | 0.1 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.0 | 0.0 | GO:0034625 | fatty acid elongation, monounsaturated fatty acid(GO:0034625) |
0.0 | 0.1 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.0 | 0.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.1 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.0 | 0.2 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.0 | 0.0 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.0 | GO:0071166 | ribonucleoprotein complex localization(GO:0071166) |
0.0 | 0.2 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.0 | 0.0 | GO:0030832 | regulation of actin filament length(GO:0030832) |
0.0 | 0.0 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.0 | GO:0097191 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.0 | 1.5 | GO:0000082 | G1/S transition of mitotic cell cycle(GO:0000082) cell cycle G1/S phase transition(GO:0044843) |
0.0 | 0.0 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.0 | 0.1 | GO:0045787 | positive regulation of cell cycle(GO:0045787) |
0.0 | 0.5 | GO:0010952 | positive regulation of peptidase activity(GO:0010952) |
0.0 | 0.0 | GO:0048539 | bone marrow development(GO:0048539) |
0.0 | 0.2 | GO:0042354 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.0 | 0.7 | GO:0030041 | actin filament polymerization(GO:0030041) |
0.0 | 0.0 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.0 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.0 | 0.0 | GO:0051168 | nuclear export(GO:0051168) |
0.0 | 0.0 | GO:0071636 | positive regulation of transforming growth factor beta production(GO:0071636) |
0.0 | 0.1 | GO:0034214 | protein hexamerization(GO:0034214) |
0.0 | 0.0 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.0 | 0.1 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.0 | 0.3 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.1 | GO:0000087 | mitotic M phase(GO:0000087) |
0.0 | 4.6 | GO:0043043 | peptide biosynthetic process(GO:0043043) |
0.0 | 0.2 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.0 | 0.0 | GO:0006828 | manganese ion transport(GO:0006828) |
0.0 | 0.2 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.0 | 0.1 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.0 | 0.0 | GO:0060760 | positive regulation of response to cytokine stimulus(GO:0060760) |
0.0 | 0.2 | GO:0036503 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) ERAD pathway(GO:0036503) |
0.0 | 0.0 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.0 | 0.4 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.0 | 0.3 | GO:0007286 | spermatid development(GO:0007286) |
0.0 | 0.6 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.1 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.0 | 0.1 | GO:0043954 | cellular component maintenance(GO:0043954) |
0.0 | 0.4 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.1 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.0 | 0.1 | GO:0070646 | protein modification by small protein removal(GO:0070646) |
0.0 | 0.0 | GO:0002467 | germinal center formation(GO:0002467) |
0.0 | 0.0 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.0 | 0.0 | GO:0009060 | aerobic respiration(GO:0009060) |
0.0 | 0.0 | GO:0016139 | glycoside metabolic process(GO:0016137) glycoside catabolic process(GO:0016139) |
0.0 | 0.6 | GO:0031294 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.0 | 0.1 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.0 | GO:0043471 | regulation of nucleotide catabolic process(GO:0030811) regulation of carbohydrate catabolic process(GO:0043470) regulation of cellular carbohydrate catabolic process(GO:0043471) regulation of cofactor metabolic process(GO:0051193) regulation of coenzyme metabolic process(GO:0051196) |
0.0 | 0.2 | GO:0009072 | aromatic amino acid family metabolic process(GO:0009072) |
0.0 | 0.7 | GO:0016071 | mRNA metabolic process(GO:0016071) |
0.0 | 0.5 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.0 | 0.1 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.0 | 0.0 | GO:0050891 | renal water homeostasis(GO:0003091) multicellular organismal water homeostasis(GO:0050891) |
0.0 | 0.1 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.0 | 1.5 | GO:0007067 | mitotic nuclear division(GO:0007067) |
0.0 | 0.0 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.0 | 0.0 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.0 | 1.1 | GO:0006396 | RNA processing(GO:0006396) |
0.0 | 0.1 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.0 | 0.0 | GO:1901998 | antibiotic transport(GO:0042891) toxin transport(GO:1901998) |
0.0 | 0.1 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.0 | 1.4 | GO:0008380 | RNA splicing(GO:0008380) |
0.0 | 0.0 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.0 | 0.1 | GO:0042462 | photoreceptor cell development(GO:0042461) eye photoreceptor cell development(GO:0042462) |
0.0 | 0.4 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.0 | 0.3 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.0 | 0.1 | GO:0008154 | actin polymerization or depolymerization(GO:0008154) |
0.0 | 0.1 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.2 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.0 | 0.1 | GO:0071214 | cellular response to abiotic stimulus(GO:0071214) |
0.0 | 0.0 | GO:0034372 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) very-low-density lipoprotein particle remodeling(GO:0034372) |
0.0 | 0.2 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.0 | 0.0 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.1 | GO:0001893 | maternal placenta development(GO:0001893) |
0.0 | 0.0 | GO:1904358 | positive regulation of telomere maintenance via telomerase(GO:0032212) positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
0.0 | 0.0 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.0 | 0.4 | GO:0006006 | glucose metabolic process(GO:0006006) |
0.0 | 0.0 | GO:0022618 | ribonucleoprotein complex assembly(GO:0022618) |
0.0 | 0.0 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.0 | 0.0 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.0 | GO:1901264 | carbohydrate derivative transport(GO:1901264) |
0.0 | 0.0 | GO:0032108 | negative regulation of response to food(GO:0032096) negative regulation of response to extracellular stimulus(GO:0032105) negative regulation of response to nutrient levels(GO:0032108) |
0.0 | 1.5 | GO:0044764 | multi-organism cellular process(GO:0044764) |
0.0 | 0.1 | GO:0032479 | regulation of type I interferon production(GO:0032479) |
0.0 | 0.0 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.0 | 0.0 | GO:0043441 | acetoacetic acid metabolic process(GO:0043438) acetoacetic acid biosynthetic process(GO:0043441) |
0.0 | 0.0 | GO:0006490 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.0 | 0.1 | GO:0009988 | cell-cell recognition(GO:0009988) |
0.0 | 0.0 | GO:0051445 | regulation of meiotic cell cycle(GO:0051445) |
0.0 | 0.0 | GO:0009070 | serine family amino acid biosynthetic process(GO:0009070) |
0.0 | 0.0 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.0 | 0.1 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 0.0 | GO:0006907 | pinocytosis(GO:0006907) |
0.0 | 1.3 | GO:0051603 | proteolysis involved in cellular protein catabolic process(GO:0051603) |
0.0 | 0.0 | GO:0003341 | cilium movement(GO:0003341) |
0.0 | 0.0 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.0 | 0.0 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.1 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.0 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.0 | 0.0 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.0 | 0.0 | GO:0019532 | oxalate transport(GO:0019532) |
0.0 | 0.0 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.0 | 0.0 | GO:0019605 | butyrate metabolic process(GO:0019605) |
0.0 | 1.3 | GO:0016568 | chromatin modification(GO:0016568) |
0.0 | 0.0 | GO:0006458 | 'de novo' protein folding(GO:0006458) |
0.0 | 0.0 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.0 | 0.2 | GO:0006518 | peptide metabolic process(GO:0006518) |
0.0 | 0.1 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.0 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.0 | 0.0 | GO:0007034 | vacuolar transport(GO:0007034) |
0.0 | 0.0 | GO:0048865 | stem cell fate commitment(GO:0048865) stem cell fate determination(GO:0048867) |
0.0 | 0.2 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.1 | GO:0009268 | response to pH(GO:0009268) |
0.0 | 0.0 | GO:0019319 | hexose biosynthetic process(GO:0019319) |
0.0 | 0.2 | GO:0070302 | regulation of stress-activated protein kinase signaling cascade(GO:0070302) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.9 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.5 | 0.5 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.4 | 1.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.3 | 0.9 | GO:0072487 | MSL complex(GO:0072487) |
0.3 | 0.8 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.3 | 2.1 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.3 | 0.8 | GO:1903561 | extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
0.3 | 0.8 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.3 | 2.3 | GO:0042555 | MCM complex(GO:0042555) |
0.2 | 2.5 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.2 | 1.0 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.2 | 0.9 | GO:0032059 | bleb(GO:0032059) |
0.2 | 0.8 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.2 | 0.8 | GO:0043218 | compact myelin(GO:0043218) |
0.2 | 0.2 | GO:0005694 | chromosome(GO:0005694) |
0.2 | 0.6 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.2 | 1.6 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.2 | 0.6 | GO:0033270 | paranode region of axon(GO:0033270) |
0.2 | 0.7 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 0.6 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.2 | 0.2 | GO:0005844 | polysome(GO:0005844) |
0.2 | 1.4 | GO:0005861 | troponin complex(GO:0005861) |
0.2 | 0.2 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.2 | 0.2 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.2 | 3.2 | GO:0031519 | PcG protein complex(GO:0031519) |
0.2 | 0.6 | GO:0030056 | hemidesmosome(GO:0030056) |
0.2 | 0.5 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.2 | 0.6 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.7 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 1.0 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.6 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 0.4 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.1 | 0.1 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 0.7 | GO:0070938 | contractile ring(GO:0070938) |
0.1 | 1.5 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 0.6 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.1 | 0.8 | GO:0016580 | Sin3 complex(GO:0016580) Sin3-type complex(GO:0070822) |
0.1 | 1.5 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 0.5 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.1 | 0.3 | GO:0044462 | external encapsulating structure part(GO:0044462) |
0.1 | 0.7 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.5 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.1 | 0.6 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.4 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.4 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.1 | 0.4 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.5 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.5 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 0.7 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 0.5 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.1 | 0.6 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 0.2 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.1 | 2.0 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.1 | 0.3 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 0.3 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.1 | 0.5 | GO:0001740 | Barr body(GO:0001740) |
0.1 | 0.2 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.1 | 1.3 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 0.5 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.2 | GO:0000800 | lateral element(GO:0000800) |
0.1 | 0.7 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 0.9 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 0.2 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.8 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 0.3 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.1 | 0.3 | GO:0044291 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.1 | 0.9 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 0.4 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 2.1 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 2.0 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 0.7 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 0.5 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.8 | GO:0016585 | obsolete chromatin remodeling complex(GO:0016585) |
0.1 | 0.4 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.7 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 0.9 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 1.7 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.3 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.1 | 0.5 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 0.3 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.1 | 0.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 0.4 | GO:0030118 | clathrin coat(GO:0030118) |
0.1 | 0.2 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.1 | 4.7 | GO:0030496 | midbody(GO:0030496) |
0.1 | 0.5 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 0.3 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 0.3 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.1 | 0.4 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 1.1 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 3.1 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.1 | 0.3 | GO:0033268 | node of Ranvier(GO:0033268) |
0.1 | 0.6 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.1 | 0.5 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 0.3 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 1.1 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 1.5 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 5.8 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 0.6 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.4 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 0.1 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.1 | 6.3 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.9 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 0.3 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 1.8 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 0.3 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.1 | 0.1 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.1 | 0.4 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.1 | 1.1 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 0.3 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 0.3 | GO:0045281 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.1 | 0.4 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 0.9 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 0.4 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 0.4 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.4 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.6 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
0.1 | 0.6 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 0.2 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.1 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 1.8 | GO:0035097 | methyltransferase complex(GO:0034708) histone methyltransferase complex(GO:0035097) |
0.1 | 0.1 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.1 | 0.3 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 0.8 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 0.2 | GO:0016939 | kinesin II complex(GO:0016939) |
0.1 | 0.7 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 0.4 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.3 | GO:0031083 | BLOC complex(GO:0031082) BLOC-1 complex(GO:0031083) |
0.1 | 6.1 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 0.3 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 0.1 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.1 | 3.3 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 1.1 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 2.5 | GO:0000785 | chromatin(GO:0000785) |
0.1 | 0.3 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 0.2 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 1.3 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.7 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 0.4 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.1 | 0.8 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 0.1 | GO:0000125 | PCAF complex(GO:0000125) |
0.1 | 0.4 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.3 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.3 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 2.3 | GO:0036064 | ciliary basal body(GO:0036064) |
0.1 | 1.5 | GO:0005657 | replication fork(GO:0005657) |
0.1 | 0.7 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.2 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 0.6 | GO:0030018 | Z disc(GO:0030018) |
0.1 | 0.3 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 0.3 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 0.2 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 0.7 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 0.6 | GO:0005840 | ribosome(GO:0005840) |
0.1 | 0.3 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 0.1 | GO:0070820 | tertiary granule(GO:0070820) |
0.1 | 5.8 | GO:0005819 | spindle(GO:0005819) |
0.1 | 1.7 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.6 | GO:0000299 | obsolete integral to membrane of membrane fraction(GO:0000299) |
0.1 | 0.3 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 0.2 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.1 | 0.4 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 0.3 | GO:1904949 | ATPase dependent transmembrane transport complex(GO:0098533) ATPase complex(GO:1904949) |
0.1 | 1.6 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.1 | 0.5 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 0.6 | GO:0045495 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.1 | 0.9 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 0.2 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 0.1 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 0.9 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 4.2 | GO:0019717 | obsolete synaptosome(GO:0019717) |
0.0 | 0.3 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.0 | 2.7 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 0.1 | GO:0044217 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.0 | 5.2 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 0.8 | GO:0031902 | late endosome membrane(GO:0031902) |
0.0 | 0.2 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.0 | 0.1 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.0 | 0.3 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 0.3 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) nuclear transcriptional repressor complex(GO:0090568) |
0.0 | 0.3 | GO:0032155 | cell division site(GO:0032153) cell division site part(GO:0032155) |
0.0 | 3.1 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 1.0 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 0.2 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.0 | 0.4 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 2.4 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 0.0 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 3.1 | GO:0005813 | centrosome(GO:0005813) |
0.0 | 0.2 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.0 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.1 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.0 | 4.2 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 0.0 | GO:0001950 | obsolete plasma membrane enriched fraction(GO:0001950) |
0.0 | 0.1 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.0 | 0.2 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.0 | 0.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.1 | GO:0008278 | cohesin complex(GO:0008278) |
0.0 | 0.1 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.1 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.0 | 3.1 | GO:0019867 | outer membrane(GO:0019867) |
0.0 | 0.0 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 1.0 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.0 | 0.2 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.0 | 0.1 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 0.9 | GO:0034774 | secretory granule lumen(GO:0034774) |
0.0 | 1.5 | GO:0030427 | site of polarized growth(GO:0030427) |
0.0 | 0.0 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.2 | GO:0070552 | BRISC complex(GO:0070552) |
0.0 | 4.1 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 0.9 | GO:0000776 | kinetochore(GO:0000776) |
0.0 | 0.7 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.0 | 1.2 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.0 | 0.2 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 0.9 | GO:0098636 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
0.0 | 0.5 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.0 | 3.1 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.2 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 2.5 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.0 | 0.5 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.0 | 0.4 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.0 | 0.2 | GO:0098791 | Golgi subcompartment(GO:0098791) |
0.0 | 1.1 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 0.1 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.0 | 0.2 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 0.0 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.0 | 33.3 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 0.0 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 3.0 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.0 | 0.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.2 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.7 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.5 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.0 | 0.2 | GO:0030126 | COPI vesicle coat(GO:0030126) COPI-coated vesicle membrane(GO:0030663) |
0.0 | 0.2 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.0 | GO:0044440 | endosomal part(GO:0044440) |
0.0 | 0.2 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.0 | 0.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.0 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.0 | 0.4 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.0 | GO:0005839 | proteasome core complex(GO:0005839) |
0.0 | 22.5 | GO:0005730 | nucleolus(GO:0005730) |
0.0 | 0.0 | GO:0048475 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.0 | 0.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 1.7 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 1.6 | GO:0005874 | microtubule(GO:0005874) |
0.0 | 0.0 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 0.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.0 | 0.1 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.3 | GO:0019861 | obsolete flagellum(GO:0019861) |
0.0 | 0.1 | GO:0043296 | apical junction complex(GO:0043296) |
0.0 | 0.1 | GO:0042627 | chylomicron(GO:0042627) |
0.0 | 1.2 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 1.2 | GO:0030141 | secretory granule(GO:0030141) |
0.0 | 0.1 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 9.4 | GO:0005654 | nucleoplasm(GO:0005654) |
0.0 | 0.5 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 4.9 | GO:0005625 | obsolete soluble fraction(GO:0005625) |
0.0 | 2.2 | GO:0030659 | cytoplasmic vesicle membrane(GO:0030659) |
0.0 | 0.2 | GO:0031090 | organelle membrane(GO:0031090) |
0.0 | 0.1 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 0.7 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.3 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.0 | GO:0005770 | late endosome(GO:0005770) |
0.0 | 0.0 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 22.1 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 0.3 | GO:0031514 | motile cilium(GO:0031514) |
0.0 | 0.1 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.7 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.1 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.0 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.0 | 0.6 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 10.5 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.5 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.0 | 0.3 | GO:0005792 | obsolete microsome(GO:0005792) |
0.0 | 1.1 | GO:0005923 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.0 | 5.4 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 0.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.0 | GO:0042581 | specific granule(GO:0042581) |
0.0 | 2.1 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.0 | 0.3 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.6 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 0.2 | GO:0015630 | microtubule cytoskeleton(GO:0015630) |
0.0 | 0.5 | GO:0098802 | plasma membrane receptor complex(GO:0098802) |
0.0 | 0.1 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.0 | 0.0 | GO:0099738 | apical cortex(GO:0045179) cell cortex region(GO:0099738) |
0.0 | 0.2 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.0 | 0.3 | GO:0000502 | proteasome complex(GO:0000502) |
0.0 | 0.0 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.0 | 35.8 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 0.0 | GO:0031674 | I band(GO:0031674) |
0.0 | 0.1 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.0 | 0.0 | GO:0044433 | cytoplasmic vesicle part(GO:0044433) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 2.3 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.5 | 1.5 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.5 | 1.4 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.4 | 1.2 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.4 | 0.8 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.4 | 1.2 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.4 | 1.2 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.4 | 0.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.3 | 1.0 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.3 | 1.4 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.3 | 1.0 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.3 | 1.0 | GO:0070052 | collagen V binding(GO:0070052) |
0.3 | 3.0 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.3 | 1.3 | GO:0031014 | troponin T binding(GO:0031014) |
0.3 | 1.0 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.3 | 1.3 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.3 | 1.2 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.3 | 0.6 | GO:0070061 | fructose binding(GO:0070061) |
0.3 | 0.9 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.3 | 0.8 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.3 | 1.4 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.3 | 0.3 | GO:0001012 | transcription regulatory region sequence-specific DNA binding(GO:0000976) RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) RNA polymerase II regulatory region DNA binding(GO:0001012) |
0.3 | 0.8 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.3 | 0.8 | GO:0030172 | troponin C binding(GO:0030172) |
0.3 | 0.8 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.3 | 0.8 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) |
0.3 | 0.8 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.3 | 1.0 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.3 | 1.0 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 1.5 | GO:0005521 | lamin binding(GO:0005521) |
0.2 | 0.7 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.2 | 0.7 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.2 | 0.9 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.2 | 0.7 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.2 | 0.9 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.2 | 0.7 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.2 | 0.9 | GO:0051425 | PTB domain binding(GO:0051425) |
0.2 | 0.9 | GO:0008469 | histone-arginine N-methyltransferase activity(GO:0008469) |
0.2 | 0.6 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.2 | 1.0 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.2 | 0.6 | GO:0034187 | obsolete apolipoprotein E binding(GO:0034187) |
0.2 | 1.4 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.2 | 0.6 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.2 | 0.6 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.2 | 1.4 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.2 | 0.6 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.2 | 0.4 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.2 | 0.8 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.2 | 1.1 | GO:0051400 | BH domain binding(GO:0051400) |
0.2 | 0.6 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.2 | 1.7 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.2 | 2.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.2 | 0.9 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.2 | 0.7 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 0.7 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.2 | 0.7 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.2 | 0.5 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.2 | 0.5 | GO:0042287 | MHC protein binding(GO:0042287) MHC class I protein binding(GO:0042288) |
0.2 | 0.5 | GO:0008061 | chitin binding(GO:0008061) |
0.2 | 0.5 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.2 | 0.4 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.2 | 0.3 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.2 | 1.9 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.2 | 0.9 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.2 | 0.3 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.2 | 0.7 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.2 | 0.2 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.2 | 1.3 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.2 | 0.8 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.2 | 0.5 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.2 | 1.0 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.2 | 0.6 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.2 | 0.8 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.2 | 0.8 | GO:0009374 | biotin binding(GO:0009374) |
0.2 | 0.6 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.2 | 0.5 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.2 | 0.5 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.2 | 0.9 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.2 | 0.3 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.2 | 0.5 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.2 | 0.6 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.2 | 0.8 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.2 | 0.5 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.2 | 1.7 | GO:0030553 | cGMP binding(GO:0030553) |
0.2 | 1.1 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.1 | 0.6 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.1 | 1.2 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 0.6 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.7 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.4 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 0.7 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 1.0 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 0.7 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.9 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 0.7 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 1.3 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.1 | 0.6 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 0.8 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.8 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.6 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.6 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.1 | 0.7 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.1 | 0.4 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
0.1 | 1.0 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.5 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 0.4 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 0.5 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.1 | 0.4 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.1 | 0.4 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 0.4 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.4 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 0.5 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 0.4 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.1 | 0.4 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.1 | 0.4 | GO:0045118 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.1 | 0.4 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.5 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 1.0 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 0.8 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.5 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.1 | 0.3 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 0.6 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.1 | 0.4 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.7 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 0.4 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.4 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.1 | 0.7 | GO:0005402 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
0.1 | 0.5 | GO:0045569 | TRAIL binding(GO:0045569) |
0.1 | 0.7 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 2.4 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.1 | 0.6 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.4 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.6 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.1 | 1.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.2 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.1 | 0.2 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.1 | 0.6 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.1 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.1 | 0.8 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.5 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.1 | 1.4 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 1.8 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.1 | 1.0 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
0.1 | 0.7 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 1.2 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 0.6 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 2.1 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.3 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.5 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 1.3 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 0.4 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 1.3 | GO:1902936 | phosphatidylinositol bisphosphate binding(GO:1902936) |
0.1 | 0.4 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 1.8 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 1.0 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.3 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.1 | 0.3 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.1 | 0.4 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 0.4 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.6 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.5 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.1 | 0.1 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.1 | 1.1 | GO:0004835 | tubulin-tyrosine ligase activity(GO:0004835) |
0.1 | 0.5 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 0.4 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 0.6 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.1 | 0.6 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 0.3 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 0.4 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 0.3 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 0.4 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 1.0 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 1.4 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 0.6 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.5 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.1 | 0.3 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 1.4 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 0.4 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.1 | 0.8 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.6 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 0.3 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.4 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.3 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.2 | GO:1990939 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.1 | 0.1 | GO:0016986 | obsolete transcription initiation factor activity(GO:0016986) |
0.1 | 0.3 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.7 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 0.4 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 0.3 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.1 | 0.9 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 0.1 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.1 | 0.4 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.1 | 0.4 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.1 | 1.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 1.5 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.1 | 0.6 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 1.2 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.1 | 0.9 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 1.0 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.1 | 0.5 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.5 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.1 | 3.8 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 2.2 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.1 | 0.1 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 0.3 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.1 | 0.5 | GO:0015520 | tetracycline:proton antiporter activity(GO:0015520) |
0.1 | 0.8 | GO:0008143 | poly(A) binding(GO:0008143) |
0.1 | 0.3 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.1 | 0.5 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 0.2 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 2.7 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.1 | 0.3 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.1 | 0.2 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.3 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 0.4 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 0.7 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 0.7 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 0.2 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.2 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.1 | 2.4 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.1 | 0.4 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.9 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.4 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.1 | 0.2 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.1 | 0.4 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.1 | 0.2 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 0.4 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.3 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.3 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.1 | 0.2 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.3 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
0.1 | 0.2 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 0.6 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 0.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.6 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 0.7 | GO:0051117 | ATPase binding(GO:0051117) |
0.1 | 0.7 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.4 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.1 | 0.3 | GO:0004064 | arylesterase activity(GO:0004064) |
0.1 | 0.4 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 0.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 2.2 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.1 | 0.6 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.1 | 0.2 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.1 | 0.2 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 0.7 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.1 | 1.5 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.4 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 2.7 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 0.7 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.5 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.1 | 0.5 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.1 | 0.2 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.1 | 0.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.4 | GO:0032451 | demethylase activity(GO:0032451) |
0.1 | 9.0 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 0.6 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 0.3 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.9 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.1 | 0.1 | GO:0005035 | death receptor activity(GO:0005035) |
0.1 | 0.2 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 0.3 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.1 | 0.6 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.4 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.4 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.1 | 0.5 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 0.3 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.1 | 0.2 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.1 | 0.7 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.1 | 0.2 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.7 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 0.8 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.1 | 0.2 | GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups(GO:0016725) |
0.1 | 0.5 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 2.4 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 0.4 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.1 | 0.1 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
0.1 | 0.3 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 4.0 | GO:0008017 | microtubule binding(GO:0008017) |
0.1 | 0.9 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 0.2 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.1 | 0.2 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 0.2 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 0.4 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 0.5 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.7 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.1 | 0.3 | GO:0030955 | potassium ion binding(GO:0030955) alkali metal ion binding(GO:0031420) |
0.1 | 1.5 | GO:0030145 | manganese ion binding(GO:0030145) |
0.1 | 0.1 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.1 | 0.4 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 0.3 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.1 | 0.1 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.3 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 0.4 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 0.5 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 0.1 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.1 | 0.3 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 0.3 | GO:0001846 | opsonin binding(GO:0001846) |
0.1 | 1.8 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.1 | 1.8 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 0.1 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.1 | 0.3 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.1 | 0.5 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 0.2 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.3 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 0.1 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.1 | 0.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.1 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.1 | 1.8 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) RNA polymerase II transcription cofactor activity(GO:0001104) |
0.1 | 0.1 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 0.2 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 0.3 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.9 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.1 | GO:0043398 | HLH domain binding(GO:0043398) |
0.1 | 0.2 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.6 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.1 | 0.4 | GO:0030547 | receptor inhibitor activity(GO:0030547) |
0.1 | 0.5 | GO:0052742 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) phosphatidylinositol kinase activity(GO:0052742) |
0.1 | 0.4 | GO:0009922 | fatty acid elongase activity(GO:0009922) |
0.1 | 0.2 | GO:0004516 | nicotinate phosphoribosyltransferase activity(GO:0004516) |
0.1 | 1.3 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 0.2 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
0.1 | 1.4 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.1 | GO:0048156 | tau protein binding(GO:0048156) |
0.1 | 0.2 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.1 | 0.1 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.4 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 0.1 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 1.2 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 0.4 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.2 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.1 | 0.2 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 0.4 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 0.5 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.1 | 0.3 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.2 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 0.8 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 0.1 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.1 | 1.8 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.1 | GO:0035258 | steroid hormone receptor binding(GO:0035258) |
0.1 | 0.4 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.4 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.3 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.1 | 0.4 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 0.5 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.1 | 0.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 0.4 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.5 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.1 | 0.5 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 0.3 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.1 | 0.1 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.1 | 0.3 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 0.5 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.1 | 0.6 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 0.5 | GO:0043621 | protein self-association(GO:0043621) |
0.1 | 1.9 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.2 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 1.0 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 0.2 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.1 | 0.1 | GO:0052866 | phosphatidylinositol phosphate phosphatase activity(GO:0052866) |
0.1 | 0.3 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.1 | 0.4 | GO:0071617 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.1 | 0.3 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 0.7 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.1 | 0.4 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.1 | 0.8 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.2 | GO:0004875 | complement receptor activity(GO:0004875) |
0.1 | 0.7 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.1 | 2.2 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 1.1 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.1 | 1.4 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.1 | 0.3 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.2 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.1 | 0.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 0.4 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 0.8 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.1 | 0.2 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.1 | 0.1 | GO:0004339 | glucan 1,4-alpha-glucosidase activity(GO:0004339) |
0.1 | 0.5 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.1 | 0.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.1 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 0.8 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.5 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 0.2 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 0.9 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 1.6 | GO:0051287 | NAD binding(GO:0051287) |
0.1 | 0.3 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 0.1 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.0 | 0.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 0.7 | GO:0008483 | transaminase activity(GO:0008483) |
0.0 | 0.2 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.0 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.0 | 0.2 | GO:0015923 | mannosidase activity(GO:0015923) |
0.0 | 0.3 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.1 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.0 | 0.1 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.0 | 0.9 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 0.1 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.7 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.0 | 0.0 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) |
0.0 | 0.1 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.0 | 0.2 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.0 | 0.1 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.0 | 0.2 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.0 | 0.9 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.0 | 0.1 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.0 | 0.2 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.0 | 0.1 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 0.4 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 1.3 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 0.6 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.0 | 0.1 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.0 | 0.2 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.1 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
0.0 | 0.4 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 0.2 | GO:0015925 | galactosidase activity(GO:0015925) |
0.0 | 0.1 | GO:0016944 | obsolete RNA polymerase II transcription elongation factor activity(GO:0016944) |
0.0 | 3.2 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.0 | 0.3 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.0 | 0.0 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.0 | 0.1 | GO:0032129 | NAD-dependent histone deacetylase activity(GO:0017136) histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) histone deacetylase activity (H3-K9 specific)(GO:0032129) protein deacetylase activity(GO:0033558) histone deacetylase activity (H4-K16 specific)(GO:0034739) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) NAD-dependent histone deacetylase activity (H4-K16 specific)(GO:0046970) |
0.0 | 0.1 | GO:0017069 | snRNA binding(GO:0017069) |
0.0 | 0.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 0.1 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.0 | 0.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.0 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.0 | 1.7 | GO:0016875 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.0 | 0.0 | GO:0042806 | fucose binding(GO:0042806) |
0.0 | 0.4 | GO:0016251 | obsolete general RNA polymerase II transcription factor activity(GO:0016251) |
0.0 | 0.0 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.0 | 0.1 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.0 | 0.5 | GO:0010181 | FMN binding(GO:0010181) |
0.0 | 0.1 | GO:0019201 | nucleotide kinase activity(GO:0019201) |
0.0 | 0.2 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.2 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.0 | 0.1 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.0 | 0.6 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.0 | 0.0 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.0 | 0.5 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 0.8 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 1.4 | GO:0003729 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.0 | 0.4 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.0 | 1.7 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.7 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.3 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.3 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.0 | GO:0035173 | histone kinase activity(GO:0035173) |
0.0 | 0.3 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.0 | 2.0 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.0 | 0.8 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.1 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
0.0 | 0.5 | GO:0000049 | tRNA binding(GO:0000049) |
0.0 | 0.4 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.0 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.0 | 0.8 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.0 | 0.1 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.0 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
0.0 | 0.1 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.1 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
0.0 | 0.1 | GO:0000987 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) core promoter proximal region sequence-specific DNA binding(GO:0000987) core promoter proximal region DNA binding(GO:0001159) |
0.0 | 0.1 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.0 | 0.9 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.0 | 0.1 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
0.0 | 0.7 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.0 | 0.5 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.2 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.2 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.8 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.3 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.6 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.0 | 0.2 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.0 | 0.5 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.1 | GO:0005217 | intracellular ligand-gated ion channel activity(GO:0005217) |
0.0 | 0.2 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.0 | 0.9 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.0 | 0.0 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.0 | 1.4 | GO:0005506 | iron ion binding(GO:0005506) |
0.0 | 0.1 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.0 | 0.1 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.0 | 0.8 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.0 | 1.7 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.0 | 0.3 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.1 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 0.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 0.4 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.1 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.1 | GO:0001784 | phosphotyrosine binding(GO:0001784) protein phosphorylated amino acid binding(GO:0045309) |
0.0 | 0.2 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.0 | 0.3 | GO:0019864 | IgG binding(GO:0019864) |
0.0 | 0.5 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.0 | 0.4 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.3 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.6 | GO:0015662 | ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism(GO:0015662) |
0.0 | 0.1 | GO:0045182 | translation regulator activity(GO:0045182) |
0.0 | 8.0 | GO:0060589 | nucleoside-triphosphatase regulator activity(GO:0060589) |
0.0 | 0.0 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.0 | GO:0016362 | activin receptor activity, type II(GO:0016362) |
0.0 | 0.0 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.2 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.0 | 0.1 | GO:0005497 | androgen binding(GO:0005497) |
0.0 | 0.1 | GO:0004802 | transketolase activity(GO:0004802) |
0.0 | 0.1 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.0 | 0.7 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 0.1 | GO:1901677 | phosphate transmembrane transporter activity(GO:1901677) |
0.0 | 0.0 | GO:1990837 | sequence-specific double-stranded DNA binding(GO:1990837) |
0.0 | 0.3 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.0 | 0.2 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 1.3 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.0 | 0.1 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 0.1 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.0 | 0.4 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.1 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.0 | 0.1 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.0 | 1.1 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.0 | 0.1 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 0.3 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.0 | 0.2 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.2 | GO:0016595 | glutamate binding(GO:0016595) |
0.0 | 1.0 | GO:0008137 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 1.1 | GO:0004527 | exonuclease activity(GO:0004527) |
0.0 | 43.2 | GO:0008270 | zinc ion binding(GO:0008270) |
0.0 | 0.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.2 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.0 | 0.1 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.0 | 0.1 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.1 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.0 | 0.1 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.0 | GO:0031013 | troponin I binding(GO:0031013) |
0.0 | 0.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.6 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.1 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.0 | 0.1 | GO:0015205 | nucleobase transmembrane transporter activity(GO:0015205) |
0.0 | 0.5 | GO:0101005 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.0 | 0.2 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.1 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.0 | 0.1 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.1 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.0 | 0.2 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 0.5 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.1 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.0 | 0.1 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.5 | GO:0008026 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.0 | 0.1 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.0 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.0 | 0.1 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.0 | 0.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.6 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.2 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 0.3 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.0 | 0.1 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.3 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.0 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 3.3 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.3 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.0 | 0.1 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.0 | 0.0 | GO:0016531 | copper chaperone activity(GO:0016531) |
0.0 | 0.3 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.0 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.0 | 0.1 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 0.0 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.0 | 4.1 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 1.8 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.0 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.0 | 0.0 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.0 | 0.1 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.0 | 0.3 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.6 | GO:0004221 | obsolete ubiquitin thiolesterase activity(GO:0004221) |
0.0 | 0.1 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.0 | 0.2 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
0.0 | 0.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.0 | 0.1 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.0 | 0.1 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 0.1 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.0 | 0.0 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.0 | 0.3 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.0 | 0.9 | GO:0004518 | nuclease activity(GO:0004518) |
0.0 | 1.2 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.0 | 0.1 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.0 | 0.0 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.0 | 0.3 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.2 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.0 | 0.1 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.0 | 0.2 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.0 | 0.0 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.2 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
0.0 | 5.2 | GO:0019001 | guanyl nucleotide binding(GO:0019001) guanyl ribonucleotide binding(GO:0032561) |
0.0 | 0.6 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 6.4 | GO:0003723 | RNA binding(GO:0003723) |
0.0 | 0.1 | GO:0045502 | dynein binding(GO:0045502) |
0.0 | 0.0 | GO:0019203 | glucose-6-phosphatase activity(GO:0004346) carbohydrate phosphatase activity(GO:0019203) sugar-phosphatase activity(GO:0050308) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.0 | GO:0016151 | nickel cation binding(GO:0016151) |
0.0 | 0.2 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 0.2 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.0 | 0.0 | GO:0008493 | tetracycline transporter activity(GO:0008493) |
0.0 | 0.2 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.0 | 0.1 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.0 | 0.1 | GO:0015926 | glucosidase activity(GO:0015926) |
0.0 | 0.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 1.2 | GO:0005516 | calmodulin binding(GO:0005516) |
0.0 | 0.1 | GO:0005372 | water transmembrane transporter activity(GO:0005372) water channel activity(GO:0015250) |
0.0 | 0.0 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.0 | 0.0 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.0 | 0.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.2 | GO:0002020 | protease binding(GO:0002020) |
0.0 | 0.4 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.0 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 0.3 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.0 | 0.8 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.0 | 0.9 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.0 | 0.4 | GO:0051213 | dioxygenase activity(GO:0051213) |
0.0 | 0.1 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.0 | GO:0034212 | peptide N-acetyltransferase activity(GO:0034212) |
0.0 | 0.1 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) protein tyrosine kinase binding(GO:1990782) |
0.0 | 0.0 | GO:0051861 | glycolipid binding(GO:0051861) |
0.0 | 0.2 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.0 | 0.0 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.0 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 0.0 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.0 | 0.0 | GO:0016835 | carbon-oxygen lyase activity(GO:0016835) |
0.0 | 0.0 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.0 | 0.0 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.0 | 0.0 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.0 | 2.2 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 0.1 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.0 | 0.8 | GO:0016564 | obsolete transcription repressor activity(GO:0016564) |
0.0 | 0.1 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.0 | 0.0 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.0 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
0.0 | 0.0 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.4 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.0 | 0.1 | GO:0005048 | signal sequence binding(GO:0005048) |
0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.2 | GO:0042625 | ATPase coupled ion transmembrane transporter activity(GO:0042625) |
0.0 | 0.0 | GO:0005548 | phospholipid transporter activity(GO:0005548) |
0.0 | 0.0 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.0 | 0.1 | GO:0004386 | helicase activity(GO:0004386) |
0.0 | 0.2 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 0.0 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.3 | GO:0042623 | ATPase activity, coupled(GO:0042623) |
0.0 | 0.2 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 2.5 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 0.6 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.2 | 1.5 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.2 | 3.9 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 2.9 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.2 | 5.3 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 3.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.2 | 0.3 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.2 | 3.6 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.2 | 1.4 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.2 | 0.6 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 4.9 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 0.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 0.7 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 5.4 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 3.7 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 0.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 6.1 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 3.5 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 0.8 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 2.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 0.5 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 1.7 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 2.6 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 0.5 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 0.5 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 1.7 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 0.9 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 0.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 0.5 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 0.5 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 0.5 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 0.8 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 0.6 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 0.4 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 2.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 2.5 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 1.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 1.3 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 0.4 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 0.9 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.1 | 0.4 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 3.0 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 0.1 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 0.8 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 1.6 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 0.5 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.7 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.1 | 1.3 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 4.7 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 0.5 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 2.0 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 1.2 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 0.7 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 1.0 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 0.4 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.6 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 1.5 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 0.7 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 1.4 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 3.1 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 0.7 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 0.6 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 0.4 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 0.8 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 0.8 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 1.0 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 0.8 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 0.8 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 1.0 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 2.5 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 2.1 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 0.4 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 0.7 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 0.7 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 1.3 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 0.3 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 0.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 0.2 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 0.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 1.2 | PID ATM PATHWAY | ATM pathway |
0.1 | 0.7 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 1.3 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 1.2 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 0.8 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 1.3 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 0.3 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 0.6 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 0.7 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 1.1 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 0.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.4 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 1.1 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.2 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.8 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 1.4 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 1.0 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.1 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.5 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.2 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.3 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.8 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 1.0 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.4 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 1.0 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.7 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.3 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 0.3 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 1.2 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.3 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.1 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.2 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.1 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.2 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.1 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.2 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.0 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.1 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 0.0 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.2 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 2.4 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.3 | 0.3 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.2 | 5.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.2 | 0.9 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.2 | 3.3 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.2 | 3.1 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.2 | 2.1 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.2 | 0.9 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.2 | 1.9 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.2 | 0.3 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.2 | 1.7 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 3.0 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.2 | 2.4 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.2 | 1.7 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.2 | 2.0 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.2 | 2.0 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 0.9 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 4.3 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 1.6 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 0.1 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.1 | 1.1 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.1 | 0.1 | REACTOME OPIOID SIGNALLING | Genes involved in Opioid Signalling |
0.1 | 2.8 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 0.1 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.1 | 1.0 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 0.5 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 1.5 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 1.0 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 2.1 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 0.2 | REACTOME S PHASE | Genes involved in S Phase |
0.1 | 1.9 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 1.7 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 1.8 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 1.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 2.0 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.1 | 1.9 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 2.6 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 0.5 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 0.8 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 0.1 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.1 | 2.7 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 0.6 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 1.7 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 2.8 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 0.1 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 2.3 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 0.8 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.1 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 0.4 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 0.6 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 0.7 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.1 | 0.4 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.1 | 0.2 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.1 | 1.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.1 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.1 | 0.7 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 0.9 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 1.3 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 0.9 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 0.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 1.5 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 0.7 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.1 | 0.4 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 0.2 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.1 | 0.9 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 3.3 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 0.8 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 1.3 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 0.7 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 2.2 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 2.2 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 2.4 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 0.6 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.1 | 0.5 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 2.0 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 1.2 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.1 | 0.4 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 0.3 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 0.1 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 1.6 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.1 | 0.5 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 0.8 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.1 | 0.3 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 0.1 | REACTOME DNA REPLICATION | Genes involved in DNA Replication |
0.1 | 0.6 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 0.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 1.0 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.1 | 0.2 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 0.5 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 0.4 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 0.4 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 0.3 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 0.2 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.1 | 0.8 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 0.1 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.1 | 0.4 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 0.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 1.0 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 0.6 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 0.6 | REACTOME TRANSCRIPTION COUPLED NER TC NER | Genes involved in Transcription-coupled NER (TC-NER) |
0.1 | 0.1 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.1 | 1.2 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 0.4 | REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | Genes involved in Formation of RNA Pol II elongation complex |
0.1 | 0.9 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 0.8 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 0.8 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.1 | 1.3 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 0.9 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 0.2 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 1.2 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.1 | 0.9 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 2.8 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.1 | 0.6 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 5.5 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 0.1 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.1 | 1.5 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 1.4 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 0.7 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 0.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 1.4 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 0.9 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.1 | 0.7 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 0.6 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 3.6 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 0.9 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 1.5 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 0.5 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 0.5 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 1.3 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.1 | 0.7 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 0.6 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.0 | 0.3 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.9 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.3 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 0.9 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.0 | 1.0 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.2 | REACTOME NUCLEOTIDE EXCISION REPAIR | Genes involved in Nucleotide Excision Repair |
0.0 | 0.9 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 0.5 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.2 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 0.6 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.8 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 1.2 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 2.5 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 2.1 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 0.8 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 0.8 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.7 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.1 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.0 | 2.3 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 9.7 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.0 | 0.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.0 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 0.6 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.5 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 0.5 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.2 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.0 | 0.1 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.0 | 1.3 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.1 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.0 | 0.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.5 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 0.9 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.4 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.1 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.0 | 0.8 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.0 | 0.4 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 0.4 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.1 | REACTOME HEMOSTASIS | Genes involved in Hemostasis |
0.0 | 0.1 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.0 | 0.3 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.4 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.4 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.6 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.3 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.0 | 0.0 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.0 | 0.5 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.9 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.0 | 0.2 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 0.0 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.4 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 1.2 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 1.4 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.6 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 1.9 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.0 | 0.9 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.2 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.5 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.0 | 1.5 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 1.8 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.9 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.0 | 0.7 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.3 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.5 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.5 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.0 | 0.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.2 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.0 | 0.4 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.7 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.2 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.0 | 0.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.3 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.0 | 0.1 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.0 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 0.1 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.0 | 0.3 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 0.0 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 1.0 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 0.4 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 0.4 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.0 | 0.0 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.0 | 0.3 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.0 | 0.1 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 2.5 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.0 | 0.6 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.2 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.1 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 1.0 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.1 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 0.3 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.6 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.0 | 1.8 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.3 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.2 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.0 | 0.2 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.2 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.3 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 0.1 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.0 | 0.0 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.0 | 0.6 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.2 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.0 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.0 | 0.0 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.0 | 0.3 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.1 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.0 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.0 | 0.5 | REACTOME DEFENSINS | Genes involved in Defensins |